Previous
Previous Product Image

European Society of Cardiology Heart Failure 2019

20 $
Next

Quality Medical Publishing Beauty Through Science 2019 Live Surgery Video Series

30 $
Next Product Image

European Society of Cardiology HFA Discoveries 2020

25 $

+ Include: 105 videos + 1116 pdfs, size: 36.4 GB

+ Target Audience: cardiologist

Description

+ Include: 105 videos + 1116 pdfs, size: 36.4 GB

+ Target Audience: cardiologist

+ Sample video: contact me for sample video

+ Topics:

10 year experience of Takotsubo Syndrome.pdf
24hour urinary sodium excretion in patients with heart failure with reduced ejection fraction treated with sacubitril valsartan.pdf
25 years of acute coronary syndrome and cardiogenic shock how have we changed.pdf
3-year follow-up results of heart failure patients included in the Journey HF-TR study.pdf
6-hours levosimendan outpatient administration in advanced heart failure Our 93 sessions experience.pdf
A comparison of in-hospital initiation of sacubitril valsartan vs ACE inhibitor in patients with acute decompensated heart failure.pdf
A link between uric acid and brain natriuretic peptide levels in heart failure with reduced ejection fraction.pdf
A method for prediction of high-grade premature ventricular contractions in patients with heart failure and preserved ejection fraction.pdf
A multi-layer spiral computed tomography role in assessment of perfusion and post-infarction myocardial remodeling in patients.pdf
A new look at urea creatinine ratio in acute decompensated heart failure patients.pdf
A novel mouse model of phospholamban p.Arg14del cardiomyopathy develops heart failure with protein aggregation.pdf
A patient reported outcomes in chronic heart failure impact of ivabradine on health-related quality of life.pdf
A qualitative study of heart failure patients’ expectations of the treatment.pdf
A randomized, double-blind, placebo-controlled trial on efficacy and safety of blumea balsamifera (sambong) on prognostic.pdf
A review of patients with Heart Failure with mid-range Ejection Fraction (HFmrEF) co-morbidities and outcomes.pdf
A review of young patients attending heart failure programmes.pdf
A simple questionnaire-based triage tool to identify patients potentially eligible for referral to an advanced heart failure center.pdf
A simplified score for bleeding risk assessment in patients with an acute coronary syndrome.pdf
A social-cognitive theory based educational intervention improving psychological health and health promoting behaviours.pdf
A structured teaching programme to improve and identify prescribing practices of common cardiac medications.pdf
A study to understand perceived educational needs of patients with heart failure in the acute medicine setting.pdf
Abnormal body water distribution as a prognostic factor in heart failure and chronic obstruction pulmonary disease patients.pdf
Abnormal spirometry increases the predictive power of ventilatory inefficiency in heart failure outpatients’ outcome.pdf
Absorbing Markov Chains for modelling progress of patients with heart failure a case study of HullLife Lab.pdf
Accurately unpensted heart failure risk prediction adhere results.pdf
Acute cardiac complications in severe influenza A H1N1 in 2019.pdf
Acute heart failure advanced cardiac life support (AHFALS) an international effort.pdf
Acute heart failure as a distinctive disorder an analysis from BIOSTAT-CHF.mp4
acute heart failure does pulse pressure predict mortality.pdf
Acute Heart failure with mid-range ejection fraction.pdf
Acute kidney injury post cardiac resynchronization therapy incidence, predictors and prognostic relevance.pdf
Acute left ventricular failure due to hypertensive crisis in patients with metabolic syndrome and type 2 diabetes mellitus.pdf
Acute mood elevation following sacubitril valsartan therapy-subgroup population of artim-hf trial.pdf
Acute myocardial infarction and kidney injury.pdf
Acute myocarditis with fluctuation of serum troponin values, a new data.pdf
Acylcarnitine profiling of patients with cardiovascular diseases.pdf
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic.pdf
Additional value of left atrial reservoir strain to the HFA-PEFF algorithm in diagnosing heart failure with preserved ejection.mp4
Additional value of left atrial reservoir strain to the HFA-PEFF algorithm in diagnosing heart failure with preserved ejection.pdf
Admission cortisol levels are associated with heart failure severity in acute coronary syndromes.pdf
Advanced therapy for advanced heart failure.pdf
Adverse impact of moderate severe mitral regurgitation on the mid-term outcome of CRT.pdf
Adverse outcome in individuals with type 2 diabetes mellitus is not a function of diabetes duration.pdf
Aetiology of heart failure in The Gambia a retrospective case series from a large clinical centre in sub-saharan africa.pdf
Age at death in heart failure relationship with etiology, sex, and cause of death.pdf
Alterations in 24 hours blood pressure assessment by ABPM in patients with hypoxia prolonged due to interstitial lung disease.pdf
Ambulatory infusion of levosimendan in advanced heart failure bridge to transplantation.pdf
Ambulatory intravenous furosemide for decompensated heart failure safe, feasible and effective in older adults.pdf
An elevated heart rate is associated with mortality in cancer patients after 1 year follow up.pdf
An integrated approach to study decongestion during hospitalization for acute heart failure a two-centre prognostic study.pdf
An old stigma in acute heart failure worsening renal function at discharge is always a big issue.pdf
An Overview of ATTR-CM Identification and Diagnosis.mp4
Analysis of electrical and mechanical dyssynchrony by electrocardiography, echocardiography and noninvasive mapping.pdf
Analysis of serum leptin in heart failure patients reveals inverse correlation to cardiac remodeling.pdf
Analysis of the mortality causes in elderly patients with atrial fibrillation.pdf
Anemia in heart failure with reduced ejection fraction – More than meets the eye.pdf
Angiopoietin-like 4 – A new jigsaw-piece in the understanding of cardiovascular remodeling.pdf
Angiotensin-(1-7) and apelin levels depending on 12-month treatment with angiotensin receptor blocker or angiotensin.pdf
Are critical patient risk scores useful for patients in cardiogenic shock in our time.pdf
Are intermediate values of BNP capable of predict events in patients with STEMI.pdf
Are patients with coronary heart disease at risk of polypharmacy.pdf
Are there any differences in taking Guideline-recommended therapy in patients with established cardiovascular diseases.pdf
Are there effects of anxiety and depression on self-care management and medication adherence in patients with heart failure.pdf
Are we doing enough by addressing heart rate to improve survival in HF.mp4
Argentine Registry of Heart Failure (ARGEN-IC). 30-day cohort.pdf
Arrythmia-induced cardiomyopathy characterization and outcomes of patients with rhythm or rate control in a population.pdf
Arterial stiffness and diastolic function alteration in essential hypertension.pdf
Artery stiffness assessed in elderly patients with heart failure and diabetes.pdf
ASPIRE.mp4
Aspirin as primary prevention of myocardial infarction, stroke, and cardiovascular mortality among diabetic patients.pdf
Aspirin use increases the risk for incident heart failure a patient-level meta-analysis.pdf
Assessing the relationship of glucose metabolism disorders and left ventricular ejection fraction in patients with chronic heart failure.pdf
Assessment of functional capacity in patients with heart failure.pdf
Assessment of malnutrition and its prognosis by risk scores in patients with acute heart failure.pdf
Assessment of of twenty-five variants of polymorphic genes for lipid and carbohydrate metabolism, vascular inflammation.pdf
Assessment of safety and renal function in ultrafiltration in patients with decompensated chronic heart failure.pdf
Assessment of the health care system resources for a management of patients with heart failure in the Russian Federation.pdf
Associated factors with recovered ejection fraction in a peruvian heart failure clinic.pdf
Association between body mass index and high-density lipoproteins with adverse outcomes in heart failure patients.pdf
Association between estimated stroke risk and left atrial remodeling in patients with atrial fibrillation does gender matter.pdf
Association between non-invasive myocardial work indices and main parameters of systolic and diastolic function.pdf
Association between NT-proBNP and some components of metabolic syndrome in patients with heart failure risk factors.pdf
Association between plasma aldosterone and diastolic function in heart failure with preserved ejection fraction.pdf
Association between right cardiac failure and endothelial dysfunction in patients with COPD.pdf
Association between use of beta-blocker and one-year outcomes of heart failure with mid-range ejection fraction.pdf
Association between variants in mycophenolate and antiviral pharmacokinetic and pharmacodynamic genes.pdf
Association of patient and regional characteristics with KCCQ recovery 6 months after hospitalization for acute heart failure.pdf
Association of ST2 and M235T polymorphism of angiotensinogen gene in heart failure patients with preserved ejection fraction.pdf
Atrial fibrillation and sleep apnea weak correlation between subjective and objective atrial fibrillation burden and severity.pdf
Atrial fibrillation and two-year prognosis in chronic heart failure.pdf
Atrial fibrillation in acute decompensated heart failure does left ventricular ejection fraction matter.pdf
Atrial fibrillation in heart failure with mid-range ejection fraction a hidden foe for women.pdf
Atrial fibrillation in heart failure with preserved ejection fraction – the PARAGON-HF trial.pdf
Atrio-ventricular junction ablation in patients with atrial fibrillation and heart failure an updated meta-analysis.pdf
Audit of acute heart failure patients discharged within 24 hours.pdf
Automatic classification of lung sounds using wavelet packets.pdf
Axial muscle size quantification by cardiac mri as a strong predictor of major cv events in hf.pdf
B-lines as reflection of left ventricle filling pressure in patients with cardiogenic dyspnea.pdf
Baroreflex activation therapy in patients with heart failure and reduced ejection fraction.mp4
BAROSTIM therapy in patients with heart failure with a reduced ejection fraction, impact in women.pdf
Based on what we know today, what should be the foundational therapy for heart failure patients Summary and Conclusion.mp4
BAUN score, a better predictive model of in-hospital and long-term outcomes in acute heart failure.pdf
Bedside ultrasound to assess acute central venous pressure change during treatment of decompensated heart failure.pdf
Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence.pdf
Beta-receptors polymorphism in cardiovascular complications genesis during flu A H1N1 epidemic.pdf
Bioelectrical impedance vector analysis (BIVA) in cardiac surgery shows an increase in postoperative hydration status.pdf
Bioimpedance-based edema index as a promising indicator of hypervolemia in heart failure.pdf
Biomarker profile of low selenium in HF patients is associated with unfavorable immune processes.pdf
biomarker sst2 as an early predictor of acute renal injury in patients with acute myocardial infarction.pdf
Biomarker utilization to predict response to beta blocker therapy.pdf
Biomarkers correspond with echo phenotype in HFpEF a secondary analysis of the RELAX trial.pdf
Biomarkers of nutritional status of HFrEF patients with iron deficiency What works, what doesn’t.pdf
Biomarkers of systemic inflammation in patients with stable coronary artery disease and chronic heart failure.pdf
Biopsy-proved lymphocytic myocarditis versus diagnosed by non-invasive methods myocarditis.pdf
Bleeding events in patients with cardiac amyloidosis.pdf
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest.pdf
Body composition alterations in right heart failure and COPD patients.pdf
Body composition evaluation in Diffuse interstitial lung disease with prolonged hypoxia.pdf
Bone metabolism disorders in patients with chronic heart failure before and after heart transplantation.pdf
Breaking the 30-day barrier long-term effectiveness of a nurse-led 7-step transitional intervention programme in heart failure.pdf
Bromocriptine protection against doxorubicin-derived toxicity in H9c2 cells.pdf
Budget impact of a personalized follow up in a Heart failure unit based on a new model of risk stratification.pdf
Burden of heart failure after an acute coronary syndrome in patients with diabetes mellitus.pdf
Cachectic versus non-cachectic chronic heart failure patients which distinctions.pdf
Calcium handling proteins of cardiomyocytes and the structural and functional state of the patient hearts with sustained.pdf
CAMISSA – The contemporary study of acute myocarditis in Sub-Saharan Africa.pdf
Can Gal-3 and ST2 biomarkers be prognosticators in heart failure- disclosures from the REFERENCE study.pdf
Can renal function predict prognosis in acute heart failure.pdf
Can TAPSE PSAP ratio predict mortality and re-hospitalization in acute heart failure patients.pdf
Can we predict chronic diuretic resistance during heart-failure hospitalization.pdf
Cardiac amyloidosis – single center experience.pdf
Cardiac contractility modulation in patients with ischemic and non-ischemic chronic heart failure and atrial fibrillation.pdf
Cardiac energy metabolism modulation is a promising way for heart regeneration and repair.pdf
Cardiac remodeling in older patients with chronic heart failure associated with chronic kidney disease.pdf
Cardiac remodelling in heart failure – the implications for patients.mp4
Cardiac remodelling in patients treated with sacubitril valsartan – what have studies shown.mp4
Cardiac resynchronization pacing in patients with chronic heart failure.pdf
Cardiac resynchronization therapy do comorbidities affect CRT response.pdf
Cardiac resynchronization therapy in Algeria, result of CRT Survey II.pdf
Cardio-renal relationships in patients with type 2 diabetes and chronic heart failure, depending on the choice of glucose-lowering therapy.pdf
Cardiomyopathy and impaired contractility in a chronic TNF-alpha mediated rheumatoid arthritis mouse model.pdf
Cardiopulmonary exercise test and sudden cardiac death risk in heart failure with reduced ejection fraction patients.pdf
Cardiopulmonary exercise testing in female heart failure patients is there a gender difference.pdf
Cardiopulmonary exercise testing in the age of new heart failure therapies still a powerful tool.pdf
Cardiovascular burden prior to diagnosis of hereditary transthyretin-mediated amyloidosis.pdf
Cardiovascular disease manifestation after breast cancer chemotherapy.pdf
Cardiovascular health metrics and risk of heart failure in men.pdf
Catheter ablation of atrial fibrillation in heart failure clinical, prognostic and echocardiographic outcome.pdf
Catheter based stimulation of the greater splanchnic nerve in a patient with heart failure and atrial fibrillation.pdf
Cerebral hemodynamics features in patients with arterial hypertension and chronic heart failure.pdf
CHA2DS2-VASC score as a mortality predictor in sinus rhythm heart failure patients.pdf
Change in QRS duration as a predictor for response to sacubitril valsartan in heart failure reduced ejection fraction.pdf
Changes in cardiac structure and function after renal revascularization in different profiles of patients with significant.pdf
Changes in furosemide dosage in patients receiving sacubitril-valsartan 2-year follow-up results.pdf
Changes in heart failure scores after sacubitril-valsartan therapy.pdf
Changes in the prevalence and etiology of chronic heart failure in 15 years.pdf
Changes of cardiac biomarkers in patients with heart failure with preserved ejection fraction and severe obstructive sleep.pdf
Changes of left ventricular ejection fraction of patients with myocarditis during long-term follow-up.pdf
Characteristics and clinical outcome by age categories in the patients with acute heart failure in Korea.pdf
Characteristics and predictors of super response to the Cardiac Resynchronisation Therapy (CRT). An Algerian single Center Experience.pdf
Characteristics of a tool for timely identification of palliative needs in heart failure.pdf
Characteristics of good response to aerobic axercise training in decompensated heart failure patients.pdf
Characteristics, evolution, complications and in-hospital morbidity and mortality according to its phenotype in patients.pdf
Characterizing a long-term chronic heart failure model by transcriptomic alterations and monitoring of cardiac remodeling.pdf
Chest computed tomography to diagnose acute decompensated heart failure in the emergency department.pdf
Cheyne stokes respiration persisting in upright position in systolic heart failure clinical and long-term prognostic value.pdf
Chronic CaMKII inhibition improves cardiac reserve in heart failure by reversing PKA signaling.mp4
Chronic CaMKII inhibition improves cardiac reserve in heart failure by reversing PKA signaling.pdf
Chronic heart failure in Argentina clinical characteristics, diagnostic strategies and treatment patterns.pdf
Chronic kidney disease… should we risk it with levosimendan.pdf
Chronic obstructive pulmonary disease in acute coronary syndrome a vicious circle.pdf
Circadian rhythm of thyroid-stimulating hormone and thyroid morphology in patients with paroxysmal atrial fibrillation.pdf
Circulating neprilysin hypothesis in HFpEF and sacubitril valsartan.pdf
Circulating signaling proteins and combined panels as markers of the response to cardiac resynchronization therapy.pdf
Citrullination of cardiac excitation-contraction coupling proteins is linked to reduced Ca2+ sensitivity of myofilament.mp4
Citrullination of cardiac excitation-contraction coupling proteins is linked to reduced Ca2+ sensitivity of myofilament.pdf
Classification of different types of hypertrophic cardiomyopathy responsible for advanced heart failure.pdf
Clinical and diagnostic meaning of estimation asymptomatic hyperuricemia in chronic heart failure patients with chronic.pdf
Clinical and economic impacts of remote management of heart failure with preserved ejection fraction.pdf
Clinical aspects in acute heart failure following an acute coronary syndrome.pdf
Clinical benefits of a personalized follow up in a Heart failure unit based on a new model of risk stratification.pdf
Clinical caracheristics of left-sided native valve infective endocarditis complicated by acute heart failure.pdf
Clinical characteristics and prognosis of heart failure patients with current malignant disease -insights from the heart failure pilot.pdf
Clinical characteristics associated with the presence of echocardiographic phenotypes of heart failure in patients with type 2.pdf
Clinical characteristics of heart failure patients in a tertiary care center in Lebanon.pdf
Clinical characteristics of patients with dilated cardiomyopathy in an asian population.pdf
Clinical characteristics, natural history and prognostic factors in patients with light chain and transthyretin cardiac amyloidosis.pdf
Clinical course of patients included in elective waiting list for heart transplantation at 6 months.pdf
Clinical decision making for right heart catheterization in patients with heart failure with preserved ejection fraction.pdf
Clinical effect of plasma exchange in patients with inflammatory dilated cardiomyopathy comparison study.mp4
Clinical effect of plasma exchange in patients with inflammatory dilated cardiomyopathy comparison study.pdf
Clinical ethics case consultation in cardiology. A pilot study and descriptive analysis of protocols.pdf
Clinical features and gender differences of patients in a heart failure clinic from a peruvian tertiary referral hospital.pdf
Clinical impact of complications on survival after Trancatheter Aortic Valve Replacement results of single center.pdf
Clinical impact of non-invasive telemonitoring in patients with chronic heart failure.pdf
Clinical outcomes and health-related costs of deranged serum potassium levels in patients with chronic cardiovascular, metabolic.pdf
Clinical outcomes in heart failure with reduced ejection fraction and good functional capacity the deception of stability.pdf
Clinical outcomes of patients with mid-range ejection fraction following ST elevation myocardial infarction.pdf
Clinical phenotypes in heart failure with preserved ejection fraction a cluster analysis of the swedish heart failure registry.mp4
Clinical phenotypes in heart failure with preserved ejection fraction a cluster analysis of the swedish heart failure registry.pdf
Clinical predictors and correlates of central and obstructive apneas in heart failure with reduced, mid-range.pdf
Clinical presentation and baseline characteristics of acute heart failure patients a single-centre experience over a 5-year period.pdf
Clinical profile & contemporary management of patients with heart failure with preserved ejection fraction.pdf
Clinical profile and outcomes in patients with hypertrophic cardiomyopathy at a tertiary care hospital in South India.pdf
Clinical profile and risk of mortality of acute heart failure in nonagenarians.mp4
Clinical profile and risk of mortality of acute heart failure in nonagenarians.pdf
Clinical spectrum and outcomes of restrictive cardiomyopathy in a tertiary care hospital in south india.pdf
Clinical Trajectory of a Real World Cohort of Patients at Risk for Heart Failure with Preserved Ejection Fraction.pdf
Clinical utility of The Selvester QRS score and ventricular activation time in patients with acute heart failure.pdf
Clinical, echocardiographic and cardiac magnetic resonance imaging features of adult patients with left ventricular non-compaction.pdf
Clustering acute heart failure patients according diastolic dysfunction degree a single centre experience.pdf
Co-morbidities of patients with chronic heart failure and anemia.pdf
Co-prescription of ivabradine and sacubitril valsartan in patients with reduced ejection fraction.pdf
Combination of arrhythmogenic right ventricular and noncompact cardiomyopathy as a special form of cardiomyopathy.pdf
COMMUNITY.mp4
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for mortality in type 2 diabetes.pdf
Compared utility of hematological indices in heart failure severity stratification.pdf
Comparison of clinical presentation and outcome between peripartum cardiomyopathy (PPCM) and dilated cardiomyopathy (DCM).pdf
Comparison of de novo and upgrade to resynchronization therapy a propensity-score matched analysis.pdf
Comparison of echocardiographic parameters between the normal and reduced LV systolic function in patients with left bundle.pdf
Comparison of GWTG and ADHERE risk scores in an inpatient and out-patient heart failure population with acute decompensation.pdf
Comparison of heart rate variability parameters among patients with different types of heart failure.pdf
Comparison of NT-proBNP concentrations when IN or OUT of HeartLogic alerts.pdf
Comparison of risk stratification scores in acute heart failure with preserved ejection fraction.pdf
Comparison of systemic metabolomic profiles in patients with various cardiomyopathies.pdf
Comparison of the in-hospital outcomes and clinical profiles among heart failure patients with good and poor nutritional status.pdf
Congestion guiding management for decompensated heart failure CONGUIMA HF Registry.pdf
congestive heart failure among hypertensive patients.pdf
Congestive heart failure in diabetic patients Epidemiological, etiological, clinical and echocardiographic features (about 1036 patients).pdf
Connection and specifics in electric myocardial inhomogeneity and stroke.pdf
Conservative versus surgical approaches in prosthetic valve endocarditis – A clinical or an echocardiographic challenge.pdf
Contemporary management of heart failure admissions.pdf
Contour analysis of pulse wave velocity and other indicators of arterial stiffness in hypertensive patients comorbid.pdf
Controversies in CRT and ICD therapy.mp4
Controversies in CRT and ICD therapy.pdf
Conventional pacemaker device upgrade to CRT-P or CRT-D in patients without previous ventricular arrhythmias.pdf
Coronary artery lesion and soluble ST2 possibilities of using the biomarker.pdf
Coronary artery stenting in patients with blood malignancy.pdf
Coronary microvascular dysfunction in HFpEF is associated with heart failure hospitalizations and cardiovascular mortality.pdf
Correlates and prognostic value of FGF23 in chronic systolic heart failure.pdf
Correlates of functional capacity in pulmonary hypertension patients.pdf
Correlates of worse NTproBNP values in a revascularized coronary artery disease cohort with obstructive sleep apnoea.pdf
Correlation between diastolic stress test results and H2FPEF score.pdf
Correlation between frequency, duration and intensity of thirst and the perceived distress.pdf
Correlation of biomarkers of cardiac remodelling and myocardial fibrosis with parameters of heart function.pdf
Creation of predictive models for the early detection of heart failure decompensations.pdf
CRT implantation in patients with borderline criteria – is it worth it.pdf
CRT SURVEY II Study Results of the Republic of Kazakhstan.pdf
Cryptogienic Stroke as the First Sign of Artrial Fibrillation in a Heart Failure Patients with Moderately Reduced Left Ventricular Ejection.pdf
CT scan findings predict decrease in pulmonary vascular resistance after pulmonary endarterectomy.pdf
Danicamtiv (MYK-491) a novel small-molecule cardiac activator in vitro in vivo evidence for overall myocardial inotropy.pdf
Dapagliflozin and diuretic use in patients with heart failure and reduced ejection fraction in DAPA-HF.mp4
Dapagliflozin in a real-world population with chronic heart failure how many would be eligible.pdf
Dapagliflozin versus sacubitril-valsartan for improving outcomes of non-diabetic patients with heart failure and reduced ejection fraction.pdf
Dapagliflozin versus sacubitril-valsartan for improving outcomes of patients with heart failure, reduced ejection fraction and type 2 diabetes.pdf
Deadly combination acute heart failure and acute coronary syndrome.pdf
Dealing with caregiver burden in advanced heart failure.pdf
DECLARE-TIMI 58 trial – analysis applied to a real world heart failure population.pdf
Decline in left ventricular ejection fraction is associated with heart failure hospitalization and sudden death in patients.pdf
Defining heart failure phenotypes.pdf
Deformation characteristics of the myocardium with different types of left ventricular remodeling.pdf
Degree of pulmonary congestion on discharge for heart failure is a strong predictor of readmission.pdf
Degree of the pre-discharge pulmonary congestion in patients hospitalized for worsening heart failure predicts one-year mortality.pdf
Degree of the Pre-discharge Pulmonary Congestion in Patients Hospitalized for Worsening Heart Failure Predicts Readmissions.pdf
Dependence of the degree of systolic dysfunction of the left ventricle on the level of natriuretic peptide and aldosterone in patients.pdf
Depression and medication adherence in patients with chronic heart failure.pdf
Describing myocarditis in the era of cardiac magnetic resonance.pdf
Despite a significant improvement in valvular indices global longitudinal strain does not improve after valve intervention.pdf
Detection of congestion with a simple risk prediction tool revealing the unrecognized.mp4
Detection of congestion with a simple risk prediction tool revealing the unrecognized.pdf
Deterioration of right ventricular function in systemic sclerosis patients with preserved left ventricular ejection fraction over time.pdf
Determinants of health-related quality of life in patients with heart failure the importance of non-clinical variables.pdf
Determinants of plasma antigen carbohydrate 125 and NT-proBNP concentrations in acute heart failure.pdf
Determinants of prolonged hospitalization in patients with heart failure and atrial fibrillation.pdf
Determination of diastolic dysfunction of the left ventricle through spectral analysis of electrocardiograms obtained.pdf
Determination of the influence of obesity on the need for energy and macronutrients of patients with chronic heart failure.pdf
Development and first-in-human implantation of a double-allogeneic engineered advanced therapy medicinal product.pdf
Development of reactive pulmonary hypertension induced by left heart failure can be predicted by the assessment of the level.pdf
Device therapies in Heart failure continuum of care time to treat!.mp4
Diabetes and chronic heart failure in Argentina a frequent association with defined characteristics.pdf
Diabetes and prediabetic dysglycaemia in patients with heart failure and preserved ejection fraction An analysis of PARAGON-HF.pdf
Diabetes and urea predict death among Brazilian outpatients with heart failure.pdf
Diabetes as a factor for increased NT-proBNP levels in patients without heart failure.pdf
Diabetes helps to refine prognosis in post-acute myocardial infarction patients with preserved ejection fraction.pdf
Diabetes in heart failure clinic in Colombia.pdf
Diagnosis of anaemia with iron deficiency predicts three-month hospitalisation in ambulatory Heart Failure patients.pdf
Diagnostic approach to transthyretin amyloidosis in a non-endemic area.pdf
Diagnostic Performance and Validation of a Novel Risk Assessment Algorithm.mp4
Diagnostic Performance and Validation of a Novel Risk Assessment Algorithm.pdf
Diagnostic screening in patients with pulmonary fibrosis the importance of echocardiographic assessment.pdf
Diagnostic value of cardiac magnetic resonance in patients after sudden cardiac arrest.pdf
Differences between perceived quality of life, functional status and level of self-care in the nurse assessed heart failure patient.pdf
Differences in characteristics between anemic and non-anemic patients hospitalized with acute heart failure.pdf
Differences in echocardiographic parameters according to the different definitions of the left bundle branch block.pdf
Differences in heart failure patients with different levels of depressive symptomatology.pdf
Differences in heart failure therapy with reduced ejection fraction therapy between Dutch heart failure clinics.pdf
Differences in quality of life among patients with left heart failure and right heart failure.pdf
Differences in symptoms of anxiety and depression between patients with left and right heart failure.pdf
Differences in the medical treatment of elderly patients with acute heart failure.pdf
Differences of functional capacity between patients with left and right heart failure.pdf
Different GRK2 expression in immune cells predicts cardiac systolic function after STEMI.pdf
Differential characteristics of acute heart failure in elderly patients.pdf
Digitalization of primary functional diagnostics data (example of electrocardiographic studies in Moscow).pdf
Direct oral anticoagulants compared to vitamin-K antagonist for the management of left ventricular thrombus.pdf
Discovering advanced heart failure patients clinical characteristics and prognostic burden.pdf
Disproportionate functional mitral regurgitation clinical validation of a new conceptual framework.pdf
Diuretic and congestion as predictors of prognosis in heart failure the importance of an early referral to Heart Failure Units.pdf
DNA methylation changes in ischemic cardiomyopathy.pdf
Do we really know why patients do not take medicines.pdf
Does global molecular calcium score have a role in HFpEF evaluation.pdf
Does NTpro-BNP BNP ratio provide additional prognostic information in an at-risk population, compared to NT-proBNP alone.pdf
Does self-care in heart failure differ between patients with reduced and preserved phenotypes.pdf
Dynamic changes in plasma extracellular RNAs are associated with right and left ventricular remodeling in chronic heart failure.pdf
Dynamics of indicators of chronic heart failure in patients after acute myocardial infarction.pdf
Dynamics of indicators of diastolic function of the left ventricle of patients with chronic heart failure during treatment.pdf
Dysregulation of actin-myosin cross-bridges contribute to the pathogenesis of RV dysfunction in pulmonary hypertension.pdf
Early aspirin use following heart transplantation the controversy continues.pdf
Early cardiac impairment in young adult survivors of childhood acute lymphoblastic leukemia and Hodgkin lymphoma.pdf
Early cardiac resynchronisation therapy in chronic heart failure.pdf
Early diagnostic of cardiac amyloidosis by global longitudinal strain echocardiography in a patient with conduction abnormalities.pdf
Early follow up visit by a heart failure team after acute heart failure hospitalization and impact in outcomes.mp4
Early follow up visit by a heart failure team after acute heart failure hospitalization and impact in outcomes.pdf
Early initiation of angiotensin receptor-neprilysin inhibitor improves heart failure outcome, natriuretic peptides.pdf
Early recurrent congestion after an acute heart failure event experience from a dedicated clinic.pdf
Early rehabilitation for heart failure inpatients – Multicenter randomized controlled trial.mp4
Early rehabilitation for heart failure inpatients – Multicenter randomized controlled trial.pdf
Early spot urinary sodium and diuretic efficiency in acute heart failure and concomitant renal dysfunction.pdf
Early urinary sodium trajectory and risk of adverse outcomes in acute heart failure and renal dysfunction.pdf
Early-onset caloric restriction maintains the mitochondrial health in left ventricle during aging.pdf
ECHO-AHF score, a predictive model of in-hospital and long-term mortality in heart failure.pdf
Echocardiographic characteristics of cardiac amyloidosis – Single center experience.pdf
Echocardiographic parameters and NT-proBNP changes during diastolic stress test in hypertensive patients with preserved.pdf
Echocardiographic parameters in women with coronary heart disease in combination with osteoporosis.pdf
Effect of 2-ethyl-6-methyl-3-oxipyridin succinate on oxidative stress and inflammation markers in patients.pdf
Effect of antimicrobal therapy on the embolic complications in patients with infective endocarditis.pdf
Effect of ARNI on ectopic activity in patients with heart failure and reduced ejection fraction.pdf
Effect of atrial fibrillation on NT-proBNP levels in patients without heart failure.pdf
Effect of comorbidity on annual mortality in patients with acute decompensated heart failure.pdf
Effect of dapagliflozin on outcomes according to aetiology in patients with heart failure and reduced ejection fraction.mp4
Effect of dapagliflozin on outcomes according to aetiology in patients with heart failure and reduced ejection fraction.pdf
Effect of dapagliflozin on outcomes in women and men with heart failure with reduced ejection fraction in the DAPA-HF trial.mp4
Effect of dapagliflozin on outcomes in women and men with heart failure with reduced ejection fraction in the DAPA-HF trial.pdf
Effect of dapagliflozin on outpatient worsening in patients with heart failure and reduced ejection fraction.mp4
Effect of Empagliflosin on certain functional and morphological myocardial parameters of rats following myocardial infarction.pdf
Effect of left ventricular ejection fraction in new-onset atrial fibrillation after a coronary syndrome.pdf
Effect of levosimendan infusion prior to left ventricular assist device implantation.pdf
Effect of phosphodiesterase-5a inhibition on pulmonary hemodynamics and right ventricular function in patients with heart failure.pdf
Effect of pulmonary rehabilitation on exercise tolerance and functional class in patients with heart failure.pdf
Effect of reduced skeletal muscle tissue density on rehospitalizations, mortality and survival rates of patients.pdf
Effect of the heart rate variability biofeedback training in right heart failure patients.pdf
Effect of Vericiguat on Left Ventricular Function The VICTORIA Echocardiographic Sub-Study.mp4
Effectiveness and safety of balloon pulmonary angioplasty in a small cohort of CTEPH patients.pdf
Effectiveness and safety of intravenous furosemide plus hypertonic saline solution in ambulatory patients with heart failure.pdf
Effectiveness of a remote control of home-based exercise training.pdf
Effectiveness of intravenous vasodilators treatment among Thai patients with acute heart failure in the emergency department.pdf
Effectiveness of nurse-led integrated care-based heart failure programmes in complex chronic patients.pdf
Effectiveness of nurse-led integrated care-based heart failure programmes in patients with moderate and advanced chronic.pdf
Effects of Dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring.pdf
Effects of dapagliflozin on hypotensive patients with depressed left ventricular ejection fraction after sacubitril valsartan therapy.pdf
Effects of different treatment regimens on high sensitive troponin T and NT-proBNP in patients with acute decompensated heart failure.pdf
Effects of early intrapericardial administration of microvesicles obtained from heart-derived cells in cardiac function.pdf
Effects of metolazone administration in patiens hospitalized for advanced heart failure and diuretic resistance.pdf
Effects of sacubitril valsartan on cardiac fibrosis and remodelling in a murine model of left ventricular dysfunction induced.pdf
Effects of Sacubitril Valsartan on exercise capacity, ventricular remodeling and natriuretic peptides in a prospective cohort of patients.pdf
Effects of tafamidis on exercise capacity, cardiac function and myocardial amyloid deposition in patients.pdf
Effects of telemonitoring on mortality and hospital admissions in patientes with heart failure.pdf
Effects on prognostic variables of anemia in heart failure Results from NATURE-HF registry.pdf
Efficacy and safety of evolocumab in hemodialyzed statin intolerant patients.pdf
Efficacy and safety of initial adjusted high dose of intravenous furosemide in outpatients with acute heart failure.pdf
Efficacy and safety of prothromin complex concentrate use to reverse oral anticoagulation in patients undergoing heart transplantation.pdf
Efficacy and safety of subcutaneous furosemide in patients with end-stage heart failure.pdf
Efficacy and security of intravenous Levosimendan, in the first 24 hours after primary angioplasty, in patients.pdf
Efficacy of conservative approach for HeartWare left ventricular assist device pump thrombosis a single center experience.pdf
Efficacy of intracoronary administration of microencapsulated hepatocyte growth factor in a reperfused myocardial.pdf
Efficacy of ivabradine in patients with chronic heart failure and chronic obstructive pulmonary disease.pdf
Efficacy of optimized torsemide versus furosemide in patients with acute heart failure.pdf
Efficacy of sacubitril valsartan in patients with heart failure following right ventricular myocardial infarction.pdf
Efficacy of sodium glucose cotransporter 2 inhibitors in reducing heart failure hospitalizations.pdf
Ejection fraction and mortality in 499,153 men and women.mp4
Electrocardiographic manifestations of STEMI is it that bad to have a right bundle branch block.pdf
Elevated GDF-15, malnutrition and heart failure in the aged a matched case-control association analysis.pdf
Elevated uric acid levels and acute heart failure different ejection fractions, same effect.pdf
Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure.pdf
Eligibility for sacubitril valsartan in heart failure across the ejection fraction spectrum.mp4
EMBRACE.mp4
Emerging data in Asian population for HF management.mp4
Empagliflozin and the risk of heart failure hospitalization, heart failure worsening and hospital readmission in routine.pdf
Empagliflozin improves functional capacity and LV diastolic function in patients with HFpEF and type-2 diabetes mellitus.pdf
Empagliflozin improves post-infarction cardiac remodeling through overexpression of GTP enzyme cyclohydrolase 1.pdf
Empagliflozin versus dapagliflozin for primary prevention of heart failure in patients with type 2 diabetes.pdf
Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor.pdf
Epidemiology of Heart Failure in South India Disease-Specific Prevalence, Phenotypic Classification, and Risk Factors.pdf
Epidemiology of potassium derangements among chronic cardiovascular conditions predisposing to heart failure.pdf
ERIC-HF program (early rehabilitation in cardiology – heart failure) – pilot study.pdf
Establishing whether shortness of breath is good predictor of obstructive coronary artery disease using SPECT myocardial.pdf
Estimating glomerular filtration rate in patient with heart failure.pdf
Estimation of mortality risk after 12-month management in a multidisciplinary HF Clinic using MAGGIC-HF, SHFM.pdf
Evaluating clinical characteristics and predictors of acute decompensated heart failure outcomes among patients.pdf
Evaluating the prognostic role of serum lactate in the cardiac transplant population.pdf
Evaluation of a regional ambulatory heart failure service an essential service in high demand.pdf
Evaluation of clinical prediction scores and NTproBNP for prediction of new onset atrial fibrillation in the STOP-HF study.pdf
Evaluation of left ventricular dyssynchrony and myocardial function by longitudinal strain exercise echocardiography in patients.pdf
Evaluation of minimum retesting interval for NT-proBNP levels in a tertiary centre.pdf
Evaluation of respiratory parameters in patients with chronic heart failure during physical exercises.pdf
Evaluation of the change six minute walking test distance with conditioning.pdf
Evolution of the residual risk in the post-myocardial revascularization period in patients with ischemic heart failure.pdf
Exercise capacity and quality of life according to iron deficiency in heart failure with preserved ejection fraction.pdf
Exercise hemodynamics on LVAD support poor left ventricle unloading despite normal hemodynamics at rest.pdf
Exercise-based cardiac rehabilitation program reduces inflammation in patients with ischaemic cardiomyopathy.pdf
Experience with the first 142 chronic heart failure patients monitored by telesurveillance program at the Toulouse University Hospital.pdf
EXPERIENCE.mp4
Experts on the Spot Cardiac remodelling and outcomes.mp4
Exploring gender differences of palliative care in patients with advanced heart failure.pdf
Exploring the prevalence and experience of cardiac cachexia in northern ireland a mixed methods cross-sectional study.pdf
Exposure to 4-hydroxynonenal impairs function of mitochondria isolated from left ventricular myocardium of dogs.pdf
Exposure to Ionizing radiation during cardiac catheterization causes GRK2 activation PBMC.pdf
Expression of miRNA-21, miRNA-128 and miRNA-342 in the serum of patients with amyloid cardiomyopathy.pdf
External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.pdf
Extracellular vesicles boost the regenerative therapeutic potential of engineered cardiac scaffolds inducing neoangiogenesis.pdf
Factors affecting the quality of life of tunisian patients with systolic heart failure.pdf
Factors associated with heart failure most affect on the mortality of patients with acute myocardial infarction.pdf
Factors associated with the presence of cirrhotic cardiomyopathy defined according to the new multidisciplinary diagnostic criteria.pdf
Factors associated with the use of sacubitril valsartan in patients with heart failure and reduced ejection fraction.pdf
Factors conditioning P2Y12 inhibitor choice after an acute coronary syndrome.pdf
Factors related to continuity of care in patients hospitalized due to heart failure.pdf
FAST-RVD score, a better predictor of in-hospital mortality in acute pulmonary embolism.pdf
Fatigue at discharge in patients with acute heart failure an important but underrated symptom.pdf
Favorable respiratory effects with a sodium-glucose cotransporter-2 inhibitor in type 2 diabetic patients.pdf
Favourable effects of empagliflozin on congestion, diuretic use and all-cause healthcare resource utilisation in the EMPERIAL.mp4
Feasibility and periinterventional complications with a novel plug device (Watchman FLX) for the interventional.pdf
Features of clinical and functional changes in patients with CHF due to CAD in combination with COPD.pdf
Features of the chronic heart failure in patients with ischemic heart disease and type 2 diabetes mellitus.pdf
Features of the metabolic status, patients in the waiting list for heart transplantation.pdf
Features of the structural and functional state of arteries in patients with HFpEF depending on renal dysfunction variant.pdf
Female patients with chronic stable heart failure report worse quality of life than men.pdf
Female patients with heart failure and a LVEF less than or equal to 60% present an overall lower health related quality.pdf
Filtration function of kidneys in patients with chronic heart failure depending on the level of left ventricular ejection fraction.pdf
Finding of ventricular non-compaction on cardiac imaging is associated with adverse events.pdf
Fluid resuscitation in patient with heart failure and septic shock outcomes.pdf
Fluid retention in patients with paroxysmal and permanent forms of atrial fibrillation and chronic heart failure.pdf
Focal activity as a trigger of atrial fibrillation in patients with heart failure.pdf
Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure a meta-analysis.pdf
Frailty in heart failure worse prognosis beyond medical treatment.pdf
Frailty in patients on the heart transplant list Results of the FELICITAR registry.pdf
Frailty in patients with acute heart failure is gender important.pdf
Frailty in patients with acute heart failure.pdf
Furosemide stress test predicts appropriate decongestion in acute heart failure patients.pdf
Gap between treatment guideline and clinical practice of sacubitril valsartan inTSOC-HFrEF registry.pdf
Gender differences in exercise rehabilitation program participation and reasons for exercises among HF patients.pdf
Gender differences in hospitalized patients with heart failure and atrial fibrillation.pdf
Gender differences in taking guideline-recommended therapy, target levels of heart rate and blood pressure in patients.pdf
Gender differences in the frequency of newly or previously diagnosed type 2 diabetes mellitus and prediabetes in patients.pdf
Gender-specific aspirin nonresponsiveness and heart failure by assessing urinary 11-dehydro thromboxane B2.pdf
General community appreciation of heart failure data from the heart failure awareness days 2019.pdf
Genetic aspects of long-term prognosis in patients with heart failure after myocardial infarction and acute kidney injury.pdf
Genetic background of the late-onset dilated cardiomyopathy.pdf
Genetic landscape and prognosis of dilated cardiomyopathy in women.pdf
Genetic predictors of acute coronary syndrome with ST segment elevation outcomes in men and women.pdf
Genetic predictors of diastolic heart failure formation in hypertensive patients.pdf
Genotype-phenotype profile of arrhythmogenic cardiomyopathies causing heart failure.pdf
Geriatric assessment of elderly patients with acute coronary syndrome.pdf
Get with the guidelines heart failure score as a mortality predictor in patients with pulmonary embolism.pdf
Global longitudinal strain as a predictor of cardiovascular events and mortality after acute myocardial infarction.pdf
Global longitudinal strain the new left ventricular ejection during an acute coronary syndrome.pdf
Glucose-lowering therapy in patients with type 2 diabetes mellitus depending on the stages of heart failure.pdf
GRACE score in acute heart failure patients an additional value.pdf
GRACE score in acute heart failure patients useful as stroke predictor.pdf
Guideline based medications and dosages in a hospital setting among heart failure patients.pdf
Guideline-recommended therapy depending on the stages of the American classification of HF.pdf
Guideline-recommended therapy in patients with type 2 diabetes mellitus depending on the presence or absence of heart failure.pdf
Gut microbiota in patients with coronary artery disease and control group.pdf
Haemoglobin has a negative impact on NT-proBNP only in patients without heart failure.pdf
Head-to-head comparison of contemporary heart failure risk scores.pdf
Health-related quality of life in multidisciplinary heart failure clinic relationships to stage D heart failure and predicted survival.pdf
Healthcare resource utilisation and health outcomes among young patients with heart failure.pdf
Heart failure and diabetes a particular subtype of patient.pdf
Heart failure and health care costs a full-population observational study.pdf
Heart failure and phenotypes in familial noncompaction cardiomyopathy.pdf
Heart Failure as a Cancer for the Heart Comparison Between HLM, a TNM-like classification, With Other Nosologies.pdf
Heart failure as a predictor of device infection after the use of antimicrobial envelope what is our reality.pdf
Heart Failure can be clinically Stable A report on the outlook of community-diagnosed heart failure patients managed in a disease.pdf
Heart Failure education patients and professionals point of view a Substudy of the INTERACT-in-HF study.pdf
Heart failure hospitalization trends during a very long-term follow-up up to 18 years.pdf
Heart failure in hypertrophic cardiomyopathy how to predict.pdf
Heart failure in octagenarians characterization and predictors of survival.pdf
Heart failure in patients undergoing elective and emergency non-cardiac surgery- Still a poorly addressed risk factor.pdf
Heart Failure in patients with longer PR interval it is easier to achieve constant fusion CRT pacing.pdf
Heart failure in the andean region a retrospective study from a cohort of patients from Colombia and Peru.pdf
Heart failure incidence in acute ST- elevation myocardial infarction patients with different total ischemic time.pdf
Heart failure management optimisation in nursing homes using point-of-care ultrasonography the HARMONIOUS study.mp4
Heart failure pharmacotherapy in dilated cardiomyopathy and its association with outcome.pdf
Heart failure prevalence in Portugal a nationwide analysis of the Portuguese national electronic health registry.pdf
Heart failure prevalence, patient characteristics and outcomes a large observational study.pdf
Heart failure profile in autoimmune diseases, analysis of the Serbian antiphospholipid syndrome patients.pdf
Heart failure readmissions, who are they A single-center retrospective study.pdf
Heart failure results in significant but non-critical telomere shortening in cardiomyocytes.pdf
Heart Failure risk score the predictive value of Get With The Guidelines.pdf
Heart failure symptom burden and its associated demographic and clinical correlates in Chinese heart failure patients.pdf
Heart failure symptom burden, prognosis and response to therapy in heart failure with preserved ejection fraction.pdf
Heart failure with preserved ejection fraction (HFpEF) in the heart failure clinic in two major tertiary level university hospitals.pdf
Heart Failure with Preserved Ejection Fraction among symptomatic patients with high-risk Hypertension.pdf
Heart Failure with Preserved Ejection Fraction due to INOCA. A Case Report.pdf
Heart failure-prognostic evaluation of the return to baseline NTproBNP value at discharge.pdf
Heart rate control in congestive heart failure patients with atrial fibrillation about 359 cases.pdf
Heart rate variability and nt-proBNP in patients with arterial hypertension and various risks of chronic heart failure developing.pdf
Heart rate variability in the presence of psychological stress and quality of life in patients with chronic obstructive pulmonary.pdf
Heart-type fatty acid binding protein testing and risk assessment of heart failure patients.pdf
HEFESTOS Score short term prognosis stratification of heart failure decompensations in primary care.pdf
Hematinic factor deficiencies beyond iron – An hidden non-cardiovascular comorbidity in acute heart failure.pdf
Hemoconcentration in order to avoid readmissions in heart failure wich laboratory markers to use.pdf
Hemodynamic consequences during anesthesia induction with propofol in heart failure – New insights from telemetry devices.pdf
Hepcidin levels and MELD-XI score in patients with decompensated chronic heart failure with different left ventricular ejection.pdf
High furosemide doses and impaired survival in heart failure patients a bicentric propensity score study.pdf
High in-hospital and 90-day mortality in acute decompensated heart failure patients from 50 centres across India.mp4
High prevalence of ESC-defined heart failure in an urban community The SOBOTA-HF study.mp4
High sensitivity troponin and treatment with sacubitril valsartan in heart failure patients with preserved ejection fraction.pdf
high-dose initiation of beta-blockers magnify adverse events in hospitalized patients with reduced ejection fraction heart.pdf
Hospice palliative care in heart failure patients.pdf
Hospital mortality predictors of infective endocarditis.pdf
Hospital wide heart failure ward round reduces mortality.pdf
Hospitalization and mortality in patients with heart failure and left ventricular ejection fraction over 40% in a real world.pdf
Hospitalizations due to heart failure major differences between East and West Germany remaining even 30 years after reunification.pdf
Hospitalized patients with heart failure; clinical landscape and management A gender perspective.pdf
Hot topics in heart failure.mp4
How does bmi influence heart failure programme outcomes-testing the obesity paradox.pdf
How does dose optimization of ARNI differ in patients with advanced renal failure.pdf
How good are we at looking for iron deficiency in a heart failure clinic.pdf
How low is ‘low-flow’ in aortic stenosis – A retrospective analysis of patients with true low flow low gradient aortic stenosis.pdf
How many of our heart failure patients would be eligible for dapagliflozin – A retrospective review.pdf
How many real world HFpEF patients would be suitable for sacubitril valsartan treatment according to the PARAGON-HF trial.pdf
How much exercise heart failure inpatients can perform.pdf
Humoral activation is superior for prognosis of chronic heart failure patients than presence of diabetes mellitus.pdf
Hybrid left ventricular reconstruction for the treatment of ischemic cardiomyopathy long-term results from one center.pdf
Hyperglycemia increases ipilimumab and nivolumab-induced cardiotoxicity modulating growth factors and NLRP3 expression.pdf
Hyperkalemia in heart failure patients with renal dysfunction in real life clinical practice Results from TREAT HF Study.pdf
Hypertension and potassium excretion a potential gene-phenotype interaction of the SCNA7.pdf
Hypertensives with heart failure with mid-range ejection fraction, does left bundle branch block matter.pdf
Hypochloraemia is associated with mortality in patients admitted with heart failure.pdf
Hypoxia Inducible Factor -1 (HIF-1) as a prognostic marker in acute decompensated heart failure.pdf
Ibrutinib mediated cardiotoxicity in a serie of cases.pdf
ID with Anaemia confers increased risk of Hospitalisation for HFrEF & HFmrEF patients but not HFpEF.pdf
Identification of a novel actin gene mutation, ACTC1 p.ASN94ILE, in a family with cardiomyopathy and conduction disease.pdf
Identification of DIO2 as a regulator of metabolic reprogramming and mitochondrial function in heart failure.pdf
Identification of three subphenotypes of cardiogenic shock.mp4
Identification of three subphenotypes of cardiogenic shock.pdf
Immune suppression for xeno-cell transplantation strategies in the porcine animal model.pdf
Impact of a heart failure clinic on morbidity, mortality and quality of life.pdf
Impact of chest radiograph on the prognosis of acute heart failure patients at the emergency department.pdf
Impact of comorbidities, medication adherence and sex differences on outcome in 25,776 heart failure patients.pdf
Impact of congenital heart disease on respiratory muscle function.pdf
Impact of haptoglobin serum level on blood biochemical parameters in patients with chronic heart failure (CHF).pdf
Impact of insulin therapy following an admission for acute heart failure effect on the risk of heart failure rehospitalization.pdf
Impact of iron deficiency in HFPEF.pdf
Impact of left ventricular ejection fraction and atrial fibrillation on Baroreflex Activation Therapy.pdf
Impact of mild or moderate pericardial efussion in patients with heart failure mortality and rehospitalization.pdf
Impact of multidisciplinary approach on heart failure signals and symptoms control of a multicenter Brazilian cohort.pdf
Impact of neurohormonal antagonists dose titration in heart failure with reduced ejection fraction.pdf
Impact of pacemaker implantation after TAVI on heart failure readmissions.pdf
Impact of prehospital i.v. furosemide on hospitalisation outcome in broad spectrum of acute heart failure patients.pdf
Impact of proteomic changes and mitochondrial calcium retention capacity on the cardioprotective modulation of.pdf
Impact of radiotherapy after chemotherapy on heart function in hodgkin and non-hodgkin adult lymphoma patients.pdf
Impact of right ventricle dysfunction on clinical outcome in patients with HFrEF.pdf
Impact Of Sacubitril Valsartan In Continuous-Flow Assist Device Patients On The Results Of Bioelectrical Impedance.pdf
Impact of sacubitril valsartan on left ventricular ejection fraction in patients with heart failure.pdf
Impact of sacubitril-valsartan on clinical-laboratorial parameters, left ventricule ejection fraction and loop diuretic doses of.pdf
Impact of sarcopenia in cardiovascular function in chronic heart failure and COPD patients.pdf
Impact of self-care on readmission and mortality in patients with chronic heart failure insights from a real world cohort of 1123 patients.pdf
Impact of sex differences and the absence of estrogen during menopause on atrioventricular mechanics and outcomes.pdf
Impact of the Extent of Chronic Kidney Disease on Survival in Bulgarian Population with Heart Failure and Preserved Ejection Fraction.pdf
Impaired endothelial glycocalyx in cancer patients with preserved systolic function.pdf
Implantable cardioverter defibrillator in advanced heart failure patients prognostic implications.pdf
Implantable cardioverter-defibrillator therapy for primary prevention of sudden cardiac death in patients with Chagas.pdf
Implementation of integrated care can reduce length of stay, all-cause 30-day readmissions and excess hospitalsitions for.pdf
Implementing Remote Device Therapies in the Modern Heart Failure Clinic.mp4
Implementing Remote Device Therapies in the Modern Heart Failure Clinic.pdf
Importance of three dimensional echocardiography in CRT patients.mp4
Importance of three dimensional echocardiography in CRT patients.pdf
Improved outcomes after cardiac resynchronization therapy can be reached by multiprofessional evaluation.pdf
Improved self-care of the heart failure patient after the implementation of a nurse consultation.pdf
Improvement of functional and biochemic parameters in patients with left ventricular assist device (LVAD).pdf
Improvement of functional class in patients with heart failure and advanced kidney disease after initiation of Sacubitril Valsartan.pdf
Improving prognostic stratification in patients with pulmonary hypertension due to left heart disease.pdf
In-hospital and long term (10-year) outcome of thromboembolic disease in a single tertiary center in Greece.pdf
In-hospital changes of iron status in patients with acute cardiac decompensation.pdf
In-hospital course of anaemia, renal insufficiency and iron deficiency in patients admitted with acute cardiac decompensation.pdf
In-hospital mortality and prognostic factors of elderly acute heart failure patients.pdf
Incidence and outcomes of in-hospital cardiac arrest in left ventricular assist device patients.pdf
Incidence of worsening renal function and its associations with drug treatment in ischemic heart failure patients.pdf
Incidence, prognosis and predictors of heart failure after transcatheter aortic valve replacement.pdf
Incomplete recovery of takotsubo cardiomyopathy is a major determinant of adverse cardiovascular outcomes.pdf
Increased gene expression and plasma levels of growth differentiation factor 15 correlate with worsening of cardiac.pdf
Incremental prognostic value of the geriatric nutritional risk index in patients more than 90 years old with heart failure.pdf
Inferior vena cava-based vs. multi-parametric approach to estimate right atrial pressure by echocardiography.mp4
Inferior vena cava-based vs. multi-parametric approach to estimate right atrial pressure by echocardiography.pdf
Inflammation and metabolic disorders as the basis of myocardial remodeling and chronic heart failure progression in metabolic.pdf
Influence of aerobic loads on the clinical state of patients with chronic heart failure.pdf
Influence of full yogic breathing on pulmonary congestion in patients with acute decompensated heart failure.pdf
Influence of low triiodothyronine syndrome on the course of heart failure in patients with a history of myocardial infarction.pdf
Influence of metformin on quality of life and 1-year prognosis in ischemic etiology chronic heart failure patients with prediabetes.pdf
Influence of parenteral iron supplementation on handgrip strength.pdf
Influence of sacubitril-valsartan on outcomes of patients with chronic heart failure in different populations.pdf
Influence of spironolactone on the reduction of myocardial fibrosis in patients with hypertrophic cardiomyopathy.pdf
Influence of systolic blood pressure on the treatment of chronic heart failure patients with reduced ejection fraction.pdf
Influence of transient arterial hypotension on the clinical features and prognosis of patients with chronic heart failure.pdf
Initial experience, clinical characteristics and outcome of heart failure patients included in a nurse-led patient management programme.pdf
Initiation of sacubitril valsartan in patients with diabetes after hospitalisation for acute decompensated heart failure.mp4
Initiation of sacubitril valsartan in patients with diabetes after hospitalisation for acute decompensated heart failure.pdf
Inotrope and inodilators – differential effects in acute heart failure and cardiogenic shock.mp4
Inotrope and inodilators – differential long term effects in advanced heart failure.mp4
Inotrope and inodilators – differential renal effects.mp4
Inotropes and Inodilators in Acute and Advanced Heart Failure.mp4
Instrumental and clinical features of antimetabolite chemotherapy-induced cardiovascular toxicity in patients with gastric cancer.pdf
Integrated heart failure specialist nurse-led pathway for the management of heart failure patients with cardiac implantable devices.pdf
Interplay between psychosocial and heart failure related factors may partially explain limitations in self-efficacy in patients.pdf
Interrelation between adropin and severity of heart failure in hypertensive patients with diabetes mellitus and obesity.pdf
Interventions to decrease thirst in heart failure patients in daily practice at the heart failure clinic.pdf
Intracoronary administration of microencapsulated IGF-1 improves cardiac function and reduces myocardial fibrosis.pdf
Intrapericardial administration of CDCs early after experimental myocardial infarction in swine safe, easy but of limited effectiveness.pdf
Intrarenal and carotid haemodynamics in patients with heart failure and preserved ejection fraction.pdf
Intravenous repletion of iron deficiency in LVAD recipients. Comparison with oral iron treatment.pdf
Introduction ; Adressing Complexities of HF treatment.mp4
Introduction.mp4
Iron deficiency and its correlation with prognostic parameters in patients with pulmonary hypertension in a Latin American cohort.pdf
Iron deficiency is associated with lower functional capacity in patients with advanced heart failure undergoing assessment.pdf
Iron deficiency is not associated with increased cardiovascular risk in patients with diabetes, chronic kidney disease and anemia.pdf
Iron deficiency with or without anaemia in cardiac amyloidosis clinical features, impact on mortality and functional status.pdf
Iron deficiency, an equally prevalent problem regardless of ejection fraction.pdf
Iron deficient and non-iron deficient heart failure in absence of anemia the comparative study.pdf
Iron in heart failure, the liver takes it all.pdf
Is donor-recipient matching by weight alone enough in heart transplantation.pdf
Is hypovolaemia a barrier to optimising disease modifying therapy in Heart Failure with Reduced Ejection Fraction.pdf
Is it realistic to OPTIMIZE guideline recommended HF therapies.mp4
Is the efficiency of statins in the protection of anthracycline-induced cardiomyopathy affected by the dose.pdf
Is the left atrial pressure a precise tool to optimize therapy in HFrEF patients Use of V-LAP a glimpe into the future.pdf
Is the nursery evaluation of a pulmonary congestion effetive by means of lung ultrasounds.pdf
Is there a connection in structural electrical remodeling of myocardium in neurological deficits in patients with ischemic stroke.pdf
Is there a role for Donor-derived cell-free DNA in the diagnosis of cardiac allograft vasculopathy (FreeDNA-CAV).pdf
It’s us, not them first use of urinary metabolite testing in heart failure patients indicates high level of adherence with life.pdf
IV iron in heart failure – what we know and what we don’t.mp4
Ivabradine as an innovative strategy and its impact on annual rehospitalization.pdf
Kidney function and heart failure risk in patients with new-onset atrial fibrillation.pdf
Knowledge, health literacy and self-care of patients with heart failure accompanied by an intrahospital management program.pdf
Late right heart failure after left ventricular assist device implantation results in significant limitation of exercise capacity.pdf
Late-Breaking Science Session 1 – Clinical Trial Update.mp4
Late-Breaking Science Session 2 – Registries.mp4
Late-Breaking Science Session 3 – HFpEF.mp4
Late-Breaking Science Session 4 – Acute Heart Failure.mp4
Late-Breaking Science Session 5 – Monitoring.mp4
Late-Breaking Science Session 6 – Pharmacotherapy.mp4
Late-Breaking Science Session 7 – Prevention.mp4
LDL-C cut-off in Heart Failure – should we follow the guidelines.pdf
Left and global ventricular cardiac decompensation can be detected early by PA- pressure telemonitoring-guided therapy.pdf
Left atrial remodelling in patients with heart failure relationship between sphericity index and functional capacity.pdf
Left ventricular global longitudinal strain and free wall strain of the right ventricle in respect to sex and systolic function.pdf
Left ventricular recovery during long-term medical treatment in comparison among morphological types of QRS complex.pdf
Left ventricular reverse remodeling prediction in ischemic cardiomyopathy patients the value of stress gated blood pool SPECT.pdf
Left ventricular reverse remodelling after sacubitril – valsartan.pdf
Left ventricular systolic dysfunction assessed by speckle tracking in asymptomatic HIV patients.pdf
Leuko-glycemic index as a prognostic marker in patients with acute heart failure.pdf
Levosimendan therapy in patients with acutely decompensated heart failure – Outcomes and mortality predictors.pdf
Levosimendan use in AMI-related and non-AMI-related acute heart failure.pdf
Levosimendan versus dobutamine in acute decompensated heart failure experience in a single tertiary institution in Asia.pdf
Life-threatening heart rhythm disturbances of women with underweight in the III trimester of pregnancy.pdf
Limiting factors for achieving maximum dose therapy in heart failure with reduced ejection fraction.pdf
Lipoprotein-associated phospholipase A2 predicts heart failure hospitalization in coronary heart disease patients.pdf
LIVE procedure for ischemic heart failure the evolution of an unique technique.pdf
Long term impact of obstructive sleep apnea in patients with acute coronary syndrome.pdf
Long-term and clinical profile of patients with heart failure with reduced ejection fraction who start treatment with.pdf
Long-term empagliflozin treatment improves cardiac function and remodeling in rats with chronic heart failure.pdf
Long-term follow up of the left ventricular function in patients after cardiac resynchronization therapy.pdf
Long-term follow-up in peripartum cardiomyopathy (PPCM) patients under mechanical circulatory support with left.pdf
Long-term results of coronary artery bypass surgery in patients with unstable angina.pdf
Long-term results of drug and interventional treatment in patients with morphologically verified nature of idiopathic arrhythmias.pdf
Long-term treatment with sympathetic nervous system blockers impact on degree of diastolic dysfunction in resistant hypertension.pdf
Loop diuretics use and outcomes in patients with heart failure a meta-analysis of observational studies involving 96,959 patients.pdf
Loss of rhythm control in heart failure with preserved systolic function accelerates mortality due to pump failure.pdf
Low dose of proANP31-67 does not affect kidney function structure, but prevents adverse cardiac remodeling independent.pdf
Low urinary sodium excretion despite elevated furosemide dose associates with poor long-term survival in chronic heart failure.pdf
Lower values of CA125 identifies patients with acute heart failure at very low risk of short-term adverse events.pdf
Lung ultrasound in acute myocardial infarction. Updating Killip & Kimball.pdf
Lung ultrasound profiles in hospitalized patients with pneumonia and concomitant chronic heart failure.pdf
Lung water quantification by cardiac magnetic resonance imaging a novel prognostic tool in heart failure.mp4
Lung water quantification by cardiac magnetic resonance imaging a novel prognostic tool in heart failure.pdf
Magnetic resonance imaging successfully detects regional hypertrophy in a mouse model of hypertrophic cardiomyopathy.pdf
Management of hypertrophic cardiomyopathy patients with mild left ventricular outflow tract obstruction.pdf
Managing the Hidden Threat of ATTR-CM.mp4
Managing the risk of re-hospitalization during long-term follow-up in specialized medical care for patients with chronic heart failure.pdf
Markers of heart failure and the risk of cardiovascular events in patients with acute myocardial infarction depending on.pdf
Matrix metalloproteinase-12 cleaved fragment of titin as a predictor of functional capacity in patients with heart failure.pdf
Maximizing the Clinical Benefit from Left Ventricular Assist Devices.mp4
Maximizing the Clinical Benefit from Left Ventricular Assist Devices.pdf
Mean platelet volume in the prediction of in-hospital complications in acute coronary syndromes.pdf
Mediation effect of depression on the relationship between sleep disturbance and quality of life.pdf
Medication adherence and quality of life among heart failure patients.pdf
Men and women with chronic systolic heart failure and with without concomitant 2 type diabetes.pdf
Metabolic effects of nesfatin-1 in hypertensive patients with abdominal obesity.pdf
Microwave spectrometry for coronary stent monitoring.pdf
Mid-range ejection fraction is the juice worth the squeeze.pdf
Mid-term mortality in patients without a transthoracic echocardiogram during the first acute heart failure episode.pdf
Mild anxiety disorders impact on atrial fibrillation patients’ direct oral anticoagulants adherence.pdf
Mild levels of pulmonary arterial pressure as a marker of poor prognosis.pdf
Mild to moderate aortic regurgitation is associated with increased all-cause mortality in patients with heart failure.pdf
Mind the gap a real world study of the treatment patterns and clinical outcomes in patients with chronic heart failure.pdf
Minimally invasive coronary artery bypass on the working heart (micscab) in patients with multivessel coronary disease.pdf
MiR-181c is downregulated in advanced heart failure.pdf
Mitochondrial damage-associated molecular patterns-induced by palmitate initiate immune responses and cause cardiomyocyte death.pdf
Mitochondrial dynamic processes in left ventricular tissue from heart failure patients.pdf
MitraClip, one year outcomes.pdf
Moderate to severely reduced global longitudinal strain predicts clinical outcome after aortic valve intervention in severe.pdf
Molecular alterations in cell traffic in heart transplant patients and their correlation with the incidence of cell rejection during.pdf
Molecular mechanisms of desensitization underlying differential effects of formyl peptide receptor 2 agonists on cardiac.pdf
Morbimortality impact of initiating a heart failure multidisciplinary program in Spain.pdf
Mortality associated factors in patients with acute heart failure in a peruvian tertiary referral hospital.pdf
Mortality benefits of 2 week wait heart failure clinic referral for a new heart failure diagnosis on the basis of N-terminal.pdf
Mortality in elderly patients with congenital heart disease.pdf
Mortality in patients with STEM does BNP help to predict.pdf
Mortality trends in an ambulatory multidisciplinary heart failure unit 2001 to 2019.pdf
Multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the sGC stimulator praliciguat over 12 weeks.mp4
Multicentre evaluation of transient and permanent malfunctions in CRT devices ongoing radiotherapy.pdf
Multicentre experience of intravenous ferric carboxymaltose in heart failure with reduced ejection fraction.pdf
Multilevel assessment of myocardial fibrosis in dilated cardiomyopathy PICP blood levels and LGE at CMR are incremental.pdf
Multiparametric assessment of congestion in patients hospitalized for acute heart failure.pdf
Multiplex proteomics for prediction of 1-year mortality and re-hospitalization in heart failure patients.pdf
Myocardial dyssynchrony and a different response to cardiac resynchronization therapy in patients with chronic heart failure.pdf
Myocardial remodeling in patients with Chagas cardiomyopathy in use of SacubitrilValsartan.pdf
N-Terminal pro-B-Type Natriuretic Peptide as a prognostic marker of mortality in acute heart failure patients Thailand perspective.pdf
Natriuretic response in elderly patients with acute heart failure.pdf
Natural course of non-severe secondary tricuspid regurgitation – insights from quantitative doppler assessment.pdf
Neurohumoral grup up-titration in specialized heart failure units.pdf
Neutrophil lymphocyte ratio and outcomes in patients with heart failure and preserved ejection fraction An analysis of PARAGON-HF.mp4
Neutrophil lymphocyte ratio and outcomes in patients with heart failure and preserved ejection fraction An analysis of PARAGON-HF.pdf
New biomarker for early prediction of myocardium reperfusion and cardiac remodeling in st-segment elevation myocardial.pdf
New potassium-binders for better heart failure with reduced ejection fraction prognosis.pdf
New profile and trends in hospitalization for heart failure in a reference center in north-eastern Argentina.pdf
New therapies in patients with advanced heart failure. Baroreflex modulation with carotid sinus nerve stimulation.pdf
Newly and previously diagnosed type 2 diabetes mellitus differences in the incidence of heart failure and clinical characteristics.pdf
Nitrates in combination with hydralazine in cardiorenal syndrome – a randomised controlled proof-of-concept study.pdf
Non-invasive prognostic variables in pulmonary arterial hypertension beyond the guidelines.pdf
Non-ischemic myocardial injury in heart failure is significantly associated with a higher symptomatic burden and higher.pdf
Non-ST elevation acute coronary syndrome in heart failure patients.pdf
Noninvasive markers of heart failure in patients with severe ischemic mitral regurgitation.pdf
Noninvasive ventilation(NIV) with auto-titrating EPAP for acute heart failure patients with chronic of obstructive pulmonary.pdf
Novel blood-based protein biomarker signature for prediction of heart failure.pdf
Novel method of measuring ionized calcium and its usefulness in cardiovascular disease.pdf
Novel model of atrial fibrillation prediction in patients with heart failure and middle left ventricular systolic function.pdf
Novel Pericardial Left Ventricular Assist Device (PALVAD) assessment via porcine and cadaveric experimental pathways.pdf
Novel pharmacological options in patients with heart failure with reduced ejection fraction.pdf
NT-proBNP Discharge target to improve prognostic in a heart failure population two concepts, one decision.pdf
Nurse as educator in the Comprehensive Heart Failure care program – are we ready for it.pdf
Off-target effects of SGLT2 blockers empagliflozin does not inhibit Na H exchanger-1 or lower intracellular Na in rat.pdf
One-year outcomes in HFrEF, HFmrEF and HFpEF patients with diabetes in the Middle East.pdf
Opening and setting the scene ; Current knowledge and knowledge gaps. What questions will ongoing CVOTs address.mp4
Optimal medical theraphy goals and challenges of implementing a heart failure treatment optimization strategy.pdf
Optimal timing and dosing of furosemide for acute heart failure patients in the emergency department.pdf
Optimization of evidence-based therapies for heart failure and reduced ejection fraction improves outcomes.pdf
Oral iron succinate increases ferritin in non-anemic patients with heart failure and iron deficiency a pilot study.pdf
Organ care system for total artificial heart recipients case series.pdf
Outcomes for Cardiogenic Shock comparing patients transferred from other hospitals with those directly admitted to a.mp4
Outcomes for Cardiogenic Shock comparing patients transferred from other hospitals with those directly admitted to a.pdf
Overlapping phenotype left ventricular noncompaction associated with dilated cardiomyopathy.pdf
Overview of Indications and Adoption of heart failure Device Therapies.mp4
Overview of Indications and Adoption of heart failure Device Therapies.pdf
Oxygen uptake during daily life domestic activities in patients with heart failure and reduced ejection fraction.pdf
Pace or Shock A Comparison of Cardiac Resynchronization Therapy Pacemakers vs. Cardiac Resynchronization Therapy Defibrillators.pdf
Palliative care in advanced heart failure not too late.pdf
Palliative care in heart failure a systematic review and meta-analysis.pdf
Panel discussion.mp4
Particle size and cholesterol content of circulating HDL correlate with cardiovascular death in chronic heart failure.pdf
Pathophysiologic and pharmacologic approaches in heart failure with preserved ejection fraction induced experimentally.pdf
Patient characteristics and drug utilization of heart failure patients prescribed SGLT2i and sacubitril valsartan.mp4
Patient characteristics and drug utilization of heart failure patients prescribed SGLT2i and sacubitril valsartan.pdf
Patient self-care behaviour is maintained over time in a population managed within a disease management programme.pdf
Patient-level risk stratification and cluster analysis to characterize heterogeneity in readmission patterns of patients.pdf
Patient-reported outcomes with empagliflozin in the EMPERIAL trials.mp4
Patients profiles in cardiologic or cardiogeratric department any difference.pdf
Patients submitted to coronary angiography after cardiorespiratory arrest predictors of mortality.pdf
Patients with type 2 diabetes mellitus and heart failure did not reach target levels of heart rate, blood pressure.pdf
Patterns of Guideline Recommended Treatment in Patients with Heart Failure at Different Economic Levels an Observational Study.mp4
Patterns of Guideline Recommended Treatment in Patients with Heart Failure at Different Economic Levels an Observational Study.pdf
Patterns of hyperkalaemia recurrence among heart failure patients in UK clinical practice.pdf
Patterns of late gadolinium enhancement in acute myocarditis, does it make the difference.pdf
PCI in patients with ostium coronary artery lesions three-year follow-up.pdf
Peak o2 consumption and ventilation improvement following sacubitril-valsartan therapy.pdf
Peculiarities of HFpEF according to renal dysfunction phenotypes.pdf
Peculiarity of severe heart failure in patients receiving antitumor treatment.pdf
Perceptions and barriers to deceased organ donation in Armenia a qualitative research.pdf
Personality factors in heart transplanted recipients.pdf
Pharmacological interventions and events during the transition phase of heart failure in patients with ejection fraction greater.pdf
Pharmacological treatment of Chronic Heart Failure with reduced Ejection Fraction (HFrEF) after implementation.pdf
Pharmacotherapy in patients with heart failure are we translating guidelines into clinical practice.pdf
Phase 2a Study of Danicamtiv (MYK-491) in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF).mp4
Phenotypic polymorphism of hypertrophic cardiomyopathy evaluated by cardiac CT.pdf
Physical activity patterns in heart transplant recipients 3-year follow-up of a randomized controlled exercise study.pdf
Physical activity predicts mortality and post-discharge re-hospitalization risk among Swedish heart failure patients.pdf
Physical signs and symptoms predict diastolic and systolic function in heart failure patients.pdf
Physical therapy in elderly patients with heart failure.pdf
Pilot evaluation of the usability and acceptability of the App ‘cuormio’ designed for patients with heart failure (HF).pdf
Plasma fibroblast growth factor 23 in heart failure with preserved ejection fraction relation to clinical severity and prognosis.pdf
Plasma immunoglobulin levels prior to cardiac transplantation are associated with post-transplantation survival.pdf
Plasma volume status and its association with in-hospital and post-discharge outcomes in decompensated heart failure.pdf
Platelet-to-lymphocyte ratio predicts readmissions in heart failure.pdf
Polymorphism rs10927875 of ZBTB17 gene and different types of left ventricular hypertrophy in patient with heart failure.pdf
Polypharmacy and potential drug-drug or food-drug interactions in atrial fibrillation.pdf
Post-MI dendritic cells trigger an adaptive immune reaction, and cytotoxic T cells persist during heart failure.pdf
Potential cardioprotective role of pituitary adenylate cyclase activating polypeptide in heart failure patients.pdf
Potential clinical application of dapagliflozin in patients with chronic heart failure in real life clinical practice.pdf
Potential contribution of mesenchymal stem stromal cell senescence into the pathogenesis of age-associated vascular diseases.pdf
Potential impact of a hypothetical sex-specific target dose in women for the treatment of heart failure with reduced ejection fraction.pdf
Potential SGLT2 inhibition in a real world cohort of HFrEF patients established on ARNI.pdf
Pre-clinical diastolic dysfunction is common in asymptomatic septuagenarians and is not reliably predicted by NT-proBNP.pdf
Predicting mortality of acute heart failure in the ICU a new application for old scores.pdf
Prediction of Atrial Fibrillation and Post Ablation Sinus Rhythm Restoration in Heart Failure Patients.pdf
Prediction of cardiovascular complications in patients with chronic heart failure during 12 months of observation.pdf
Predictive factors of lung function in patients with heart failure and COPD.pdf
Predictors for readmission or death during very early and early vulnerable phases in heart failure.pdf
Predictors of 12-month mortality in chronic heart failure and reduced left ventricular ejection fraction.pdf
Predictors of acute kidney injury in acute decompensated heart failure treated as outpatients with bolus intravenous.pdf
Predictors of continuous positive airway pressure compliance in patients with obstructive sleep apnea and paroxysmal atrial.pdf
Predictors of early outcome in heart failure reduced ejection fraction patients attending to an outpatient heart failure.pdf
Predictors of heart failure in patients with lymphomas receiving antitumor therapy with anthracyclines.pdf
Predictors of improvement in cardiovascular outcomes in patients with reduced left ventricular ejection fraction.pdf
Predictors of long term outcome in patients with heart failure with preserved ejection fraction.mp4
Predictors of long term outcome in patients with heart failure with preserved ejection fraction.pdf
Predictors of long-term mortality in women and men with heart failure with preserved ejection fraction.pdf
Predictors of Mortality in Bulgarian Patients with Heart Failure and Diabetes Mellitus.pdf
Predictors of need of non- invasive ventilation in acute coronary syndrome.pdf
Predictors of persistent pulmonary hypertension after pulmonary endarterectomy in CTEPH.pdf
Predictors of rehospitalization and mortality in acute decompansated hf patients.pdf
Preliminary results of the Spanish multicentric HeartLogic (RE-HEART) Registry a blinded analysis.pdf
Preliminary results of the Spanish multicentric HeartLogic (RE-HEART) Registry adoption of an alert.pdf
Prescribing patterns of acute management and guideline-directed medical therapy in admitted acute heart failure (AHF).pdf
Prescription of guideline-recommended therapy and clinical outcomes before and in the era of sacubitril valsartan.pdf
Preserved ejection fraction and structural heart disease in 446,848 patients.mp4
Prevalence and association of electrocardiogram abnormalities with clinical characteristics and outcomes in patients.pdf
Prevalence and determinants of bone disease in patients with chronic heart failure – a prospective cohort study.pdf
Prevalence and mortality in patients with heart failure according to measurement of HbA1c.pdf
Prevalence and prognosis of cardiac cachexia in acute heart failure patients.pdf
Prevalence and prognostic impact of adquired somatic mutations in patients with heart failure and reduced ejection fraction.pdf
Prevalence of central and obstructive apneas in heart failure with reduced, mid-range and preserved ejection fraction.pdf
Prevalence of cirrhotic cardiomyopathy according to the old and new diagnostic criteria.pdf
Prevalence of comorbidities among patients with heart failure with reduced and preserved ejection fraction a systematic review.pdf
Prevalence of heart failure in Colombia a secondary analysis of the official information sources.pdf
Prevalence of hyperkalemia in patients with chronic heart failure in real life clinical practice Results from TREAT HF Study.pdf
Prevalence of iron deficiency by different definitions and their association with mortality in patients with heart failure.pdf
Prevalence of iron deficiency in patients with advanced heart failure undergoing assessment for heart transplantation.pdf
Prevalence of prior history of soft tissue structures affectation in patients with cardiac amyloidosis.pdf
Prevalence pulmonary congestion by lung ultrasound among the patients with acute myocardial infarction.pdf
Prevalence, etiology and diagnostic workup of iron deficiency in patients with heart failure based on ejection fraction.pdf
Prevalence, factors related, and prognostic significance of subclinical pulmonary congestion at hospital discharge in patients.mp4
Prevalence, factors related, and prognostic significance of subclinical pulmonary congestion at hospital discharge in patients.pdf
Proactive screening for symptoms may be the key to early detection of previously unrecognised heart failure, atrial fibrillation.pdf
Profile of hospitalized patients with heart failure admitted in an intensive care department of a tertiary care hospital.pdf
Profile of infective endocarditis patients at a non-surgical center.pdf
Prognosis and prognostic factors in dilated cardiomyopathy.pdf
Prognosis of patient with chronic heart failure role of comorbidity.pdf
Prognosis of postinfarction ventricular septal rupture.pdf
Prognostic impact of BNP in patients presenting with STEMI and acute heart failure.pdf
Prognostic impact of digoxin use in a heart failure population.pdf
Prognostic impact of sleep-disordered breathing in hospitalized patients following acute decompensated heart failure.pdf
Prognostic impact of worsening renal function and unsuccessful decongestion at discharge for patients hospitalized with heart failure.pdf
Prognostic impact of worsening renal function in B-type acute heart failure patients on decongestion.pdf
Prognostic implications of myocardial work in patients with reduced left ventricular ejection fraction a preliminary study.pdf
Prognostic Importance of Permanent Atrial Fibrillation in Decompensated Heart Failure.pdf
Prognostic model of the development of the first non-cardioembolic ischemic stroke.pdf
Prognostic power of cardiovascular biomarkers with relation to duration of type 2 diabetes mellitus.pdf
Prognostic predictors for cardiac death and heart failure rehospitalization in emergency transported congestive heart failure.pdf
Prognostic relevance of left ventricular longitudinal strain in HFpEF Insights from the PARAGON-HF Echocardiographic Sub-Study.pdf
Prognostic role of vascular endothelial growth factor- A in patients with chronic heart failure with preserved ejection fraction.pdf
Prognostic uility of galectin-3 in Vietnamese patients with acute heart failure.pdf
Prognostic value of BNP in patients receiving sacubitril-valsartan 2-year follow-up results.pdf
Prognostic value of frailty in very elderly patients (over 90 years) with heart failure.pdf
Prognostic value of high sensitive troponin T in patients hospitalized for heart failure.pdf
Prognostic value of Killip classification in acute coronary syndrome 50 years later.pdf
Prognostic value of laboratory and structural-functional aspects of cardiovascular system remodeling in patients.pdf
Prognostic value of novel measures of left atrial structure and function in the elderly.pdf
Prognostic value of plasma volume variation status calculated at admittance at intensive cardiovascular care unit.pdf
Prognostic value of pulmonary artery indexed diameter assessed by cardiac magnetic resonance imaging in patients.pdf
Prognostic value of submaximal cpet variables in heart failure patients with biventricular pacing.pdf
Prolonged use of pentoxifylline prevents progression of myocardial perfusion disturbance and reduces inflammation.pdf
Promising biomarkers in patients with low left ventricule ejection fraction.pdf
Prospective assessment of early ejection fraction recovery after newly diagnosed heart failure.pdf
Prospective evaluation of the Multisensor ICD Algorithm for Heart Failure Monitoring.pdf
Prosthetic valve endocarditis vs native valve endocarditis does surgery even the odds.pdf
Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients.pdf
Psychological factors predictive of quality of life in right heart failure.pdf
Psychometricevaluation of the Polish version of the theSelf-care of HeartFailure Index a newtool for self-careassessment.pdf
Pulmonary artery pressure monitoring in LVAD patients The Cardiologist’s Perspective; Take-Home message.mp4
Pulmonary capillary wedge pressure prediction in the first year after heart transplant using BNP.pdf
Pulmonary embolism and malignant diseases.pdf
Pulmonary endarterectomy in CTEPH clinical and hemodynamic long term effect.pdf
QTc interval and qrs duration reduction following sacubitril-valsartan therapy.pdf
Quality improvement of chronic heart failure endpoints and treatment using an organized multidisciplinary program.pdf
Quality of life of patients with chronic obstructive pulmonary disease and right heart failure and their caregivers.pdf
Quality of life two years after admission to a heart failure clinic.pdf
Quantitative determinations of plasma volume demonstrate that clinical exam and formulaic estimates mislead diuretic therapy.mp4
Quantitative determinations of plasma volume demonstrate that clinical exam and formulaic estimates mislead diuretic therapy.pdf
Racial and ethnic differences in NT-proBNP concentrations and reverse cardiac remodeling in patients with systolic heart failure.pdf
Racial differences in hospice care outcomes among patients with advanced heart failure systematic review and meta-analysis.pdf
Rationale and design of the august-ahf study a randomized controlled trial to investigate the effects of yiqifumai lyophilized.pdf
RBP4 induces pyroptosis in cardiomyocytes via activating NLRP3 Caspase-1 GSDMD pathway in acute myocardial infarction.pdf
Real world characteristics and economic burden of patients with and without heart failure worsening after cardiac.pdf
Real world experience of sacubitril and valsartan in patients with heart failure with reduced ejection fraction.pdf
Real world heart failure… far, far away from guidelines.pdf
Real world impact of acute kidney injury on outcomes of patients with acute heart failure.pdf
Real world prevalence and temporal trends of heart failure stages A, B and C epidemiology in South-European population.pdf
Real-world evaluation of an intravenous iron service for treatment of iron deficiency in patients with heart failure.pdf
Real-world use of sacubitril-valsartan in the South of England.pdf
Reasons for diuretic change among heart failure patients at different stages of the HF syndrome in the outpatient setting.pdf
Red cell distribution width (RDW) is correlated to time of oxygen desaturation less 90% and length of sleep apneas in patients.pdf
Reduced expression of the G protein-coupled receptor kinase 2 (GRK2) in the endothelium accelerates the process of aortic valve.mp4
Reduced expression of the G protein-coupled receptor kinase 2 (GRK2) in the endothelium accelerates the process of aortic valve.pdf
Reduced physical activity in patients with heart failure a study based on objective measurement of daily exercise.mp4
Reduced physical activity in patients with heart failure a study based on objective measurement of daily exercise.pdf
Reduction in hospital admissions, emergency department visits, and prognosis of elderly patients managed in a hospital.pdf
Refractory postcardiotomy shock predictors of mortality in a contemporary cohort.pdf
Region-related differences in psychosocial impact among heart failure patients living with an ICD.pdf
Regional differences in use and outcomes among left ventricular assist device carriers in Europe The PCHF-VAD registry.pdf
Regional innervation perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict.pdf
Rehabilitation programs in patients with chronic heart failure.pdf
Rehmannia glutinosa oligosaccharide enhances the efficacy of Nkx2.5 gene transfected bone marrow mesenchymal stem.pdf
Rehospitalization by heart failure, mortality and prognosis in nonagenarians after stemi.pdf
Relationship between clinical characteristics and achievement of the sacubitril valsartan dosage in patients.pdf
Relationship between clinical characteristics and the occurrence of adverse effects with sacubitril valsartan in patients.pdf
Relationship between N-terminal prohormone brain natriuretic peptide and haemodynamic function in pulmonary arterial.pdf
Relationship between uric acid and N-terminal pro-B-type natriuretic peptide with severity of heart failure patients.pdf
Relationship late gadolinium enhancement on cardiovascular magnetic resonance and longitudinal ejection fraction.pdf
Relationships between markers of myocardial injury and myocardial work indices in amateur half-marathon runners.pdf
Relationships between pulmonary hypertension risk and clinical profile in dilated cardiomyopathy.pdf
Relative expression of the calsequestrin 2 gene in the myocardium of patients with heart failure.pdf
Remote Patient Management for the Post-COVID-19 Era Practical experience from Greater Manchester.mp4
Remote Patient Management for the Post-COVID-19 Era Practical experience from Greater Manchester.pdf
Renal function over time in patients with chronic heart failure with a reduced left ventricular ejection fraction using anticoagulants.pdf
Renal function trajectories and congestion assessment in patients with acute heart failure.pdf
Renal sympathetic denervation attenuates congestive heart failure in angiotensin II-dependent hypertension.pdf
Renal sympathetic denervation in patients with resistant arterial hypertension technical approach and follow-up.pdf
Renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure.pdf
Respective benefits of cardiac rehabilitation and valsartan-sacubitril association in patients with heart failure and impaired.pdf
Resting and exercise haemodynamic determinants of quality of life in left ventricular assist device patients.pdf
Results of treatment of lymphocytic myocarditis with mycophenolate mofetil compared with azathioprine (pilot study).pdf
Resynchronization induces left ventricular regional protein expression changes in a mouse model of heart failure.pdf
Retrospective review of 12 months readmission and mortality in acute heart failure patients.pdf
Revascularization in Ischaemic Heart Failure CABG, PCI or medical treatment.pdf
Reversal of tetracycline-induced infarct size limitation in obese rats with chemically induced colitis.pdf
Reverse cardiac remodeling operation in non-ischemic dilated cardiomyopathy patients.pdf
Reversing cardiac remodelling and improving outcomes in heart failure what are our first-choice treatments.mp4
Right heart dysfunction staging system for mortality risk stratification in heart failure with preserved ejection fraction.mp4
Right heart dysfunction staging system for mortality risk stratification in heart failure with preserved ejection fraction.pdf
Right to left ventricular basal diameter ratio on pulmonary angio-CT.pdf
Right ventricular free wall strain versus conventional echocardiographic parameters for right ventricular function.pdf
Right ventricular function in chronic constrictive pericarditis.pdf
Right ventricular remodeling and predictors of survival after pulmonary tromboendarterectomy.mp4
Right ventricular remodeling and predictors of survival after pulmonary tromboendarterectomy.pdf
Right ventricular to left ventricular internal diameter in diastole predicts right ventricular failure after left ventricular.pdf
Right-systolic function and iron deficiency in acute heart failure.pdf
Risk factors for anaemia in heart failure.pdf
Risk guided fluid-management strategy to reduce acute decompensated heart failure readmissions – The Risk-HF study.pdf
Risk of coronary stents restenosis and nonalcoholic steatohepatitis.pdf
Risk prediction of 30-day unplanned re-admission or mortality for heart failure patients.pdf
Risk predictor score for 90-day readmission or death in heart failure acute decompensated heart failure registry.pdf
Risk stratification in heart failure with mid-range left ventricular ejection fraction the role of cardiopulmonary exercise testing.pdf
Robotic exosuit-assisted movement therapy in advanced chronic heart failure.pdf
Role of cytokine imbalance in the formation of structural and functional changes of right ventricle in patients with chronic.pdf
Role of imaging techniques in arrhythmia-induced cardiomyopathy characterization.pdf
Role of iron during heart failure.pdf
Role of mineralocorticoid receptor antagonists in alterations of fibrosis markers galectin -3, matrix metalloproteinase-1.pdf
Role of pulmonary lymphatic circulation in congestive heart failure.pdf
s territorial longitudinal strain able to predict the coronary artery disease culprit lesion in acute coronary syndromes.pdf
Sacubitril Valsartan for HfrEF in oncological patients does the etiology matter.pdf
Sacubitril valsartan what does the real-life experience tell us.pdf
Sacubitril-valsartan in patients with NT-proBNP levels outrange of PARADIGM-HF trial inclusion criteria.pdf
Sacubitril-valsartan prescription during heart failure hospitalization real-world initial experience.pdf
Safety and efficacy of beta-blockers titration by trained heart failure nurses in heart failure patients attending to an outpatient.pdf
Safety and efficacy of the combination of sacubitril valsartan and SGLT2i in HFrEF patients (SECSI Registry).pdf
Safety and tolerability of co-administration of angiotensin receptor neprilysin inhibitor (ARNI) & sodium-glucose.pdf
Safety of a novel oral NLRP3 inflammasome inhibitor, dapansutrile (OLT1177), in patients with stable heart failure.pdf
Safety of Sacubitril Valsartan in patients with Glomerular Filtration under 40.pdf
Safety of weekly titration regimen with Sacubitril Valsartan. Tolerance and benefits in clinical practice.pdf
Screening for mutations in hungarian patients with cardiac transthyretin amyloidosis using capillary sequencing.pdf
Self-reported physical activity and anemia in ambulatory patients with heart failure.pdf
Serial measurement of circulating biomarkers in patients with acute heart failure correlates and prognostic value.pdf
Sex differences in biomarkers associated with coronary microvascular dysfunction among patients with heart failure.pdf
Sex-based differences in biomarkers, quality of life, and reverse cardiac remodeling patients with heart failure with reduced.pdf
Sex-based differences in cardiac structure and function in heart failure with preserved ejection fraction.pdf
Sex-related differences in cardiac wild-type transthyretin amyloidosis.pdf
SGLT-2 inhibitors in heart failure beyond glycaemic control.mp4
SGLT2 inhibition Making waves in the heart failure landscape.mp4
SGLT2 inhibitors A snapshot into their evolution.mp4
Short-term endothelial toxicity of adjuvant chemotherapy in solid cancer patients.pdf
Should we redefine hypertensive response in stress test to better predict cardiovascular risk.pdf
Significant impact of prescription bias in the treatment of chronic systolic heart failure on outcome.pdf
Signs of depression predict mortality among Swedish heart failure patients.pdf
Silent strokes and cognitive function in patients with chronic heart failure and sinus rhythm.pdf
Simultaneous dual isotope rest nuclear myocardial perfusion scintigraphic study.pdf
Simultaneous measurement of sST2 and Nt-proBNP at discharge helps to predict early mortality in acute decompensated.pdf
Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor (sacubitril valsartan).pdf
Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor therapy in heart failure patients.pdf
Six-month and one-year outcomes with the novel PASCAL transcatheter valve repair system for patients with functional.pdf
Sleep apnea in heart failure in search of a better prognosis predictor.pdf
Sleep disordered breathing in heart failure association with biomarkers and clinical parameters.pdf
Soluble ST2 in predicting unfavourable course of revascularization in patients with STEMI.pdf
Some mechanisms of diastolic heart failure formation in postmenopause.pdf
Specific Activity Scale is more accurate than NYHA classification for identifying patients with mild functional capacity.pdf
Speech analysis to evaluate acute heart failure patient clinical status.pdf
Spot urinary sodium as a predictor of diuretic response in decompensated heart failure.pdf
Spot urine sodium predicts effectiveness of decongestion in acute heart failure.pdf
STING-inhibitor in myocardial remodelling after myocardial infarction.pdf
Stop of high-salt diet in rats with one-kidney one-clip renovascular hypertension leads to a decrease in blood pressure.pdf
Strain echocardiography in predicting heart failure in patients with STEMI with a mid-range ejection fraction.pdf
Stress echocardiography in assessing early postinfarction myocardial dysfunction in epicardial obesity.pdf
Stress echocardiography in multivessel coronary artery disease – 12 months follow up.pdf
Stress hyperglycemia ratio in short term prognostic prediction in acute heart failure.pdf
Stress induced left ventricular diastolic dysfunction in non-severe chronic obstructive pulmonary disease patients.pdf
Stress induced right ventricular diastolic dysfunction in non-severe COPD.pdf
Study of prevalence of sleep disordered breathing in indian heart failure population.pdf
Study of prognostic markers for stable systolic heart failure for 1 year.pdf
Study of the effectiveness of mineralocorticoid receptor antagonists on neurohumoral parameters in patients with chronic.pdf
Studying of a role the matrix metalloproteinases and their tissue inhibitors in a pathogenesis of a heart failure at patients.pdf
Studying the value of plasma ngal in the diagnosis of cardiorenal syndrome type 1.pdf
Subclinical congestion understanding accuracy of physical examination in chronic heart failure outpatients.pdf
Successful development of an ambulatory intravenous iron service for patients with heart failure with reduced ejection fraction.pdf
Sudden death in heart failure with preserved cardiac function.pdf
Suppressed cardiac hepcidin expression promotes cardiac iron deficiency in postinfarction heart failure.pdf
Survey on patient perspectives about guideline-recommended disease management for chronic heart failure the VISIT-HF study.pdf
Survival and clincial outcomes in patients with stenosis aortic underwent with Transcatheter Aortic Valve Replacement.pdf
Survival and clinical outcomes of patients with deteriorate bioprosthesis compared with aortic stetnosis underwent.pdf
Symptom burden in patients with advanced heart failure.pdf
Synthesis and assessment of the biological properties of peptide [MeArg1, NLe10]-apelin-12.pdf
Tafamidis prevents deterioration of physical performance in patients with transthyretin amyloid cardiomyopathy.pdf
Telbivudine reduces Parvovirus B19 Non-Structural protein-1-induced apoptosis and NALRP3 inflammasome activation.pdf
Tele-yoga in patients with heart failure – A feasibility, pilot study and RCT protocol.pdf
Telemonitoring versus standard of care in heart failure.mp4
Telomeric machinery alterations in ischemic cardiomyopathy.pdf
Temporal trends and predictors of in-Hospital death in patients hospitalized for heart failure in Germany.mp4
Temporal trends and predictors of in-Hospital death in patients hospitalized for heart failure in Germany.pdf
Temporal trends in chronic heart failure phenotypes 20-year changes in a nationwide registry.pdf
Temporal trends in one-year outcomes of chronic heart failure patients across two decades findings from a nationwide registry.pdf
Temporal trends in the implementation of treatments for chronic heart failure two decades in a nationwide registry.pdf
Tenascin C promotes endothelial dysfunction accompanied with cardiac fibrosis in a mouse model of Duchenne Muscular Dystrophy.pdf
Testing of some methods for predicting systolic heart failure in stable patients.pdf
The affinity of the nictemeral blood pressure variability patterns to intrarenal hemodynamics in patients with HFpEF.pdf
The age-dependent variation of calculated plasma volume indices in patients admitted to intensive cardiovascular care unit.pdf
The analysis of clinical factors affecting ability to work in patients in working age with heart failure with reduced left.pdf
The ARISE-HF study development of AT-001 for the treatment of diabetic cardiomyopathy rationale and study design.pdf
The burden associated with hospitalizations for US patients with heart failure and LVEF less than or equal to 60%.pdf
The characterization of main clinical phenotypes in patients with HFpEF in a Romanian cohort.pdf
The combination therapy of pembrolizumab and trastuzumab exerts cardiotoxic and pro-fibrotic properties in preclinical models.pdf
The comparison between non-ischemic cardiomyopathy and ischemic cardiomyopathy after levosimendan use for acute.pdf
The difference admission makes – Is self care superior in patients who have had admissions with acute decompensated heart failure.pdf
The differences in clinical presentation and mortality outcomes in acute heart failure patients with ischaemic versus.pdf
The dynamics of central hemodynamics parameters in patients with different types of left ventricular remodeling after acute.pdf
The dynamics of chronic heart failure indicators in patients with different left ventricle geometry after acute myocardial infarction.pdf
The effect of beta blocker therapy in patients with acute heart failure.pdf
The effect of breathing technique training on cardiac function in patients with heart failure.pdf
The effect of combination therapy on endothelial function and vascular stiffness in patients with heart failure with preserved.pdf
The effect of functional mitral valve regurgitation in patients with chronic heart failure.pdf
The effect of hemodynamic alterations on intrarenal venous flow patterns.pdf
The effect of iron replacement on functional outcomes in a cohort of iron deficient HFpEF and HFmrEF patients.pdf
The effect of long-term therapy with atorvastatin on the quality of life of patients in the post-infarction period.pdf
The effect of the frequency and severity of hyperkalaemia on health outcomes in heart failure patients.pdf
The effect of thymosin beta-4 domains on post-hypoxic cardiac regeneration and repair.pdf
The effectiveness of trimetazidine in the prevention of contrast-induced nephropathy and major adverse cardiovascular events.pdf
The effects of aerobic physical training on muscle tissue in heart failure patients with normal body mass.pdf
The efficiency of eplerenon in complex treatment of the patients with arterial hypertension, atrial fibrillation.pdf
The efficiency of stem cell therapy in patients with ischemic heart failure after STEMI.pdf
The evolution of the parameters of chronic heart failure and the effectiveness of long-term therapy with atorvastatin.pdf
The feasibility of a structured multidisciplinary team approach to palliative care in patients with heart failure.pdf
The frequency of severe mitral regurgitation in patients completing a heart failure program which would be potentially.pdf
The furosemide dose urinary sodium concentration ratio predicts mortality in chronic stable heart failure.pdf
The gender gap in cardiac resynchronisation therapy.pdf
The HEart faiLure carer support Programme feasibility study of the HELP intervention for carers (Protocol).pdf
The HERMeS Trial (Heart failure Events reduction with Remote Monitoring and eHealth Support).pdf
The hole of hope Balloon atrial septostomy for left ventricle unloading during VA-ECMO.pdf
The huge impact in left ventricular reverse remodelling of a single drug A real-world data with ARNI.pdf
The impact of a structured heart failure disease management care program on the outcome of patients with heart failure.pdf
The impact of anaemia on systolic function of left ventricle in patients with acute coronary syndrome.pdf
The impact of de novo use of Sacubitril Valsartan in dilated cardiomyopathy.pdf
The impact of glomerular filtration rate in patients with heart failure and cardiovascular implantable electronic devices.pdf
The impact of inflammation and fibrosis in the occurrence of AF in heart failure patients with preserved ejection fraction.pdf
The impact of intolerance of beta blockers in patients with heart failure with reduced ejection fraction (HFrEF) in patients.pdf
The impact of mineralocorticoid receptor antagonist use on all-cause mortality in acute heart failure patients stratified.pdf
The impact of percutaneous mitral valve repair with mitraclip in cardiopulmonary performance.pdf
The impact of SGLT2 inhibitors on heart failure exacerbations, hospitalisations and major adverse cardiovascular events.pdf
The incidence of acute heart failure in patients with ST- elevation myocardial infarction depending on renal function.pdf
The influence of age on the circadian rhythm of arterial stiffness index in patients with chronic heart failure.pdf
The interplay of genetics and inflammation affecting left ventricular reverse remodelling in recent-onset dilated cardiomyopathy.pdf
The Left Ventricular Global Function Index in older patients with chronic heart failure optimal cut-off for admission prediction.pdf
The miRNA199a Sirt1 p300 Yy1 sST2 signaling axis regulates adverse cardiac remodeling following MI.pdf
The more the merrier double check discharge planning to improve the results of a heart failure programme.pdf
The most common electrocardiographic phenomena detected in the IT centre of the department of functional diagnostics.pdf
The next level in CRT new clinical evidence.mp4
The nomogram of plasma NGAL in the prognosis in-hospital all-cause mortality of cardiorenal syndrome type 1.pdf
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.mp4
The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.pdf
The ORIGAMI registry initial results.pdf
The pathway to home for intravenous frusemide.pdf
The potential beneficial effect of levosimendan in milrinone-treated advanced heart failure patients.pdf
The potential usefulness of hemoconcentration in guiding ambulatory heart failure management.pdf
The predictive value of the cardiac sympathetic activity and contractile function in cardiac resynchronization therapy.pdf
The predictors of progression of myocardial dysfunction in patients with nSTEMI within 6 months of follow-up.pdf
The prevalence of bone tissue metabolism disorders in patients in early terms after heart transplantation.pdf
The prevalence of frailty and heart failure in a pre-geriatric population hospitalised for cardiovascular disease.pdf
The prevalence of iron deficiency and anemia in patients of cardio-oncology clinic.pdf
The prognostic value of pulmonary artery systolic pressure in heart failure.pdf
The quality of coronary vein visualization in cardiac CT depending on the type of heart failure.pdf
The relation between frailty and cause of death and hospitalisation in patients with chronic heart failure.pdf
The relationship between body mass index, body composition and oxygen uptake in patients with heart failure.pdf
The relationship between cardiovascular and renal comorbidities and hyperkalaemia in a large real-world cohort of UK.pdf
The relationship of human herpes virus type 6 markers in the development of adverse cardiovascular events in patients.pdf
The relevance of a multidomain assessment in older patients with heart failure.pdf
The results of complex nosological diagnostics of acute and chronic pericarditis and specific treatment options.pdf
The results of the treatment of atrial fibrillation associated with chronic rheumatic heart disease with the method of transvenous.pdf
The risk of sudden cardiac death in children with apparently structurally normal heart.pdf
The role of anaemia in dilated cardiomyopathy.pdf
The role of body mass index (BMI) in dilated cardiomyopathy.pdf
The role of cardiac biomarkers elevation in intermediate-high risk pulmonary embolism.pdf
The role of cytomegalovirus infection in the development of adverse cardiac events in ischemic heart failure patients.pdf
The role of intravenous iron therapy on the arrhythmic burden of HFrEF patients with iron deficiency and cardiac implantable.pdf
The role of ionized calcium in the reversion of the ventricular fibrillation and torsades de pointes.pdf
The role of iron deficiency, RDW and EPO in heart failure prognosis – Data from the REFERENCE study.pdf
The role of macrophage migration inhibitory factor in prediction of adverse outcomes after st-segment elevation myocardial infarction.pdf
The role of novel speckle tracking echocardiography parameters in left ventricular remodeling prediction after acute.pdf
The role of OCT and measuring FFR to improve the efficiency of PCI on patient with left main bifurcation lesions.pdf
The role of single-nucleotide G634C polymorphism of the VEGF-A gene in patients with acute myocardial infarction.pdf
The S2PLIT-UG score, a novel system identifying patients with a high risk of all-cause mortality following acute.pdf
The secreted glycoprotein ADAMTSL2 is up-regulated in heart failure and directs anti-fibrotic signalling in cardiac fibroblasts.pdf
The SGLT2 inhibitor dapagliflozin exerts cardioprotective effects against doxorubicin and trastuzumab toxicity through TLR4.pdf
The Shrunken pore syndrome is associated with lower quality of life and increased risk of mortality in a Swedish heart failure population.pdf
The similarities and differences, and role of global longitudinal strain in heart failure with mid-range and reduced ejection fraction.pdf
The spontaneously hypertensive rat with permanent coronary artery ligation is a relevant model of advanced heart failure.pdf
The sST2 level in prediction of heart failure decompensation in patients with acute myocardial infarction.pdf
The STAND-UP AHF (STudy Assessing Nitoxyl Donor Upon Presentation with Acute Heart Failure).mp4
The systole diastole ratio in patients with acutely decompensated heart failure.pdf
The Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.mp4
The trip allele of Gly460Trp polymorphism and the association between systolic blood pressure and sodium potassium excretion.pdf
The use of echocardiography left ventricular filling pressures in hypertensive patients with heart failure and preserved.pdf
The use of remote telemonitoring to help in the decision of upgrading CRT-P to CRT-D.pdf
The usefulness of the existing guidelines for performance of endomyocardial biopsy in patients with suspected myocarditis.pdf
The Utility of Psychosocial Evaluation via the SIPAT Tool in Predicting Post-LVAD Hospitalizations.pdf
The VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) trial.mp4
The VITALITY-HFpEF Trial (Evaluate the Efficacy and Safety of the Oral sGC Stimulator Vericiguat to Improve Physical Functioning.mp4
Therapeutic adherence and quality of life of right heart failure patients.pdf
Therapeutic genome editing using CRISPR Cas9 for arrhythmogenic cardiomyopathy induced pluripotent stem cells.mp4
Therapeutic genome editing using CRISPR Cas9 for arrhythmogenic cardiomyopathy induced pluripotent stem cells.pdf
Thirst experience of Icelandic patients with chronic heart failure.pdf
Thirty-day outcomes with the novel PASCAL transcatheter valve repair system in patients with tricuspid regurgitation.pdf
Three-year follow-up of PCI in patients with true left main bifurcation lesions.pdf
Time course of left ventricular reverse remodeling in response to cardiac resynchronization therapy.pdf
Time to change for the sake of our heart failure patients.mp4
Time to diagnosis of new-onset heart failure in children with no known heart disease.pdf
Time to first appropriate implantable cardioverter defibrillator shock in patients with chagasic or ischemic cardiomiopathy.pdf
Time until fibrinolytic therapy in pulmonary embolism, what is the prognostic impact.pdf
Timely heart failure specialist input with urgent heart failure clinic reduces death or all-cause hospitalisation.pdf
Timing the medications can improve the outcomes in heart failure patients.pdf
Tongue coating microbiome data distinguish patients with chronic heart failure from healthy.pdf
Total bilirubin as a marker for adverse outcomes in heart failure patients a systematic review.pdf
Transcatheter Mitral Valve Repair Therapy New standard of care in Secondary Mitral Regurgitation.mp4
Transcriptomic analysis of the spliceosome in cardiac tissue of patients with heart failure.pdf
Translating findings from the landmark DAPA-HF study.mp4
Translating findings from the landmark DAPA-HF study.pdf
Transthyretin amyloid cardiomyopathy opportunistic diagnosis where is wally.mp4
Transthyretin amyloid cardiomyopathy opportunistic diagnosis where is wally.pdf
Transthyretin cardiac amyloidosis insights from a tertiary hospital.pdf
Treating heart failure decompensation in a day-hospital A safe alternative instead of an emergency room visit.pdf
Treating hyperkalaemia A step towards achieving optimal RAASi therapy.mp4
Treatment for heart failure at discharge. Do we comply with the guidelines Sub-analysis of the Argen-IC Registry.pdf
Treatment of advanced heart failure with hemodialysis hospital readmission rate and long-term outcome.pdf
Treatment of high-risk acute heart failure patients in intensive cardiac care and general intensive care units.pdf
Treatment-dependent cardiac remodeling and function in newly diagnosed brest cancer patients.pdf
Trends in epidemiology and mortality in acute coronary syndrome, complicated by cardiogenic shock.pdf
TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction (DoPING-HFpEF).pdf
Trimethylamine in exhaled breath in patients with chronic heart failure.pdf
Troponin reduction following Sacubitril-Valsartan therapy.pdf
Troponin T to NT-proBNP as predictor of acute coronary syndrome during admission for acute heart failure.pdf
Two-year outcomes with the Cardioband tricuspid valve reconstruction system from the multicentre, prospective TRI-REPAIR study.pdf
Types of patients adherence to the guideline-recommended therapy and its impact on hospitalizations and all-cause mortality.pdf
Ubiquinol reduces miRNA-34a expression in the development of monocrotaline-induced pulmonary hypertension in rats.pdf
Ultrasound B-lines on antero-lateral and posterior chest differences in decongestion rates and prognostic values.pdf
Ultrasound criteria for assessing the effectiveness of diuretic therapy in patients with chronic heart failure.pdf
Ultrasound indices of congestion in patients with acute heart failure according to body mass index.pdf
Unconventional antibiotic combinations successfully challenge standard chemotherapy for initial treatment of prosthetic.pdf
Universal definition of heart failure – Trilateral cooperative meeting of Heart Failure Association.mp4
Unveiling coronary inflammation by perivascular fat angio-ct a propensity-matched score analysis.pdf
Urine electrolyte assessment in patients with acute heart failure managed on an outpatient basis.pdf
Usability study and preliminary results of the use of ThessHF, a heart failure app developed by physicians for patients.pdf
Use of sacubitril – valsartan in octogenarian patients.pdf
Use of sodium glucose co-transporter 2 inhibitors in patients with cardiovascular disease and heart failure.pdf
Use of the prostaglandin pathway for the treatment of pulmonary arterial hypertension in the real world in Argentina.pdf
Usefulness of remote-monitoring intrathoracic fluid alerts for echo-guided CRT optimization.pdf
Usefulness of the implementation of an electronic form in the management of the patient hospitalized for heart failure (HF) baseline.pdf
Usefulness of the implementation of an electronic form in the management of the patient hospitalized for heart failure (HF) checklist.pdf
Usefulness of the implementation of an electronic form in the management of the patient hospitalized for heart failure (HF) use.pdf
Usefulness of the surprise question for predicting mortality in advanced heart failure patients.pdf
Using high-fat diet high-dose streptozotocin hybrid in vivo model for the study of epigenetic changes in diabetic cardiomyopathy.pdf
Using quality control story to implement multidisciplinary-team care in heart failure.pdf
Utility of intervaled training versus circuit in patients whit heart failure.pdf
Utility of myocardial deformation imaging to reveal potential myocardial fibrosis in patients with clinically suspected.pdf
Utility of nebivolol in cardiovascular rehabilitation.pdf
Utility of nucleocytoplasmic transport as a marker in critical heart failure with circulatory assistance as a bridge to transplant.pdf
Validation of the prognostic values of various instantaneous pulmonary arterial wedge pressure measurements.pdf
Validation of the Seattle heart failure model (SHFM) in an Iranian heart failure population.pdf
Valvular heart disease in setting of acute heart failure.mp4
Vascular dysfunction and decreased exercise capacity in childhood cranial and craniospinal tumors survivors.pdf
Ventricular tachyarrhythmia detection by Implantable loop recording in Patients with HFPEF Results of The VIP-HF study.mp4
Video + AI solution captures peripheral oedema data fully automatically without requiring patient compliance.pdf
Visually assessed apical rocking and septal flash by echocardiography.pdf
Welcome.mp4
Welcoming and scope of the session.mp4
What are the echoocardiographic parameters that have a prognosis value in chronic heart failure.pdf
What are the reasons for low rates of biventricular pacing within a CRT-D population undergoing remote follow up.pdf
What are the trigger factors of rehospitalization for acute heart failure.pdf
What have we learned from head-to-head studies of IV iron Discussion Questions and Answers.mp4
What matters most – Size, performance or technique.pdf
Which parameters of myocardial deformation are useful for clinical presentation of patients with acute myocarditis.pdf
Which Patient Outcomes are Most Meaningful in Heart Failure.pdf
Who is the patient with heart failure considered to be vulnerable – Characterization of a subgroup.pdf
Why heart failure medications are altered during non-heart failure related admissions.pdf
Worsening HF Episodes Outside a Hospital Setting in Heart Failure with Preserved Ejection Fraction the PARAGON-HF Trial.pdf
Worsening renal function and renal recovery in acute heart failure.pdf
X-ray phase contrast imaging of endo-myocardial biopsies following heart transplantation – agreement with classical histology.mp4
X-ray phase contrast imaging of endo-myocardial biopsies following heart transplantation – agreement with classical histology.pdf
Xanthine metabolism in chronic heart failure patients with chronic kidney disease.pdf

Reviews

There are no reviews yet.

Be the first to review “European Society of Cardiology HFA Discoveries 2020”

Your email address will not be published.